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Abstract: NMR (Nuclear Magnetic Resonance) has been expanding its application since 
it was first discovered in the early 50s. In biophysics, it is a very powerful tool 
complement to X-ray crystallography for protein structure studies. In this dissertation, 
two different projects studied by two different NMR methods will be presented. In the 
first part, a membrane protein PLIN1 which resides on the surface of the cellular 
organelle lipid droplet is investigated by solid-state NMR (ssNMR). It has been shown 
that PLIN 1 exclusively locates on the surface of lipid droplet and upon phosphorylation, 
recruits lipase to digest the triglycerides stored in the lipid droplet. However, due to its 
membrane protein nature, its insolubility resists to crystallization. ssNMR is a perfect tool 
to study this membrane protein. PLIN1 was reconstituted into DMPG liposomes and 
multi-dimensional ssNMR spectra were acquired. According to proton spin diffusion 
data, a membrane interaction model was proposed and later verified by both molecular 
dynamics (MD) simulation and experimental reconstitution data. In the second part, a 
soluble protein Mortalin was studied by solution NMR. Mortalin is a heat shock protein 
70 (HSP70) family membrane primarily located in the mitochondria. In cancer cells, 
Mortalin is released to the cytoplasm and forms a complex with p53, sequestering it in 
the cytoplasm thus inhibiting its translocation to nucleus to induce cell apoptosis. The 
flexible heteroarotinoid (Flex-Het) SHetA2 with promising anti-cancer activity can bind 
to Mortalin and release p53 from the complex to induce cell apoptosis. We successfully 
determined the substrate binding pocket of Mortalin to be the interacting sites with 
SHetA2 by chemical shift perturbation (CSP). Using AutoDock as the prediction tool, at 
least two binding configurations of SHetA2 are generated with high binding affinity. 
According to these results, more SHetA2 analogs were designed and tested in AutoDock. 
We find that the analogs with longer linkers that can occupy both configurations of 
SHetA2 yield the highest binding affinity (lowest binding energy). These results will 
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Nuclear Magnetic Resonance (NMR) spectroscopy has been continuously expanding its 
application areas since it was discovered after World War II when Bloch [1] at Stanford and 
Purcell [2] at Harvard reported NMR in bulk water and paraffin, respectively. The growth 
accelerated even more after the developments of pulsed Fourier transform NMR spectroscopy and 
the conception of multidimensional NMR spectroscopy. Despite its application in physics first, it 
is widely used in chemistry, biology, pharmaceutical and clinical diagnosis (MRI) nowadays.  
NMR theory is based on the spin angular momentum, an intrinsically quantum mechanical 
property that does not have a classical analog.  However, precession can be used to help visualize 
the behavior of the nucleus under external magnetic fields. The precession of the nuclear spin 
results an oscillating current that can be readily detected as free induction decay (FID). NMR has 
been a relatively insensitive method due to the fact that it detects the population difference 
between two states of the interested nuclei. In protein structure determination, X-crystallography 
is the dominant method. When the first NMR structure of a small protein BPTI was published, the 
reaction from the well-established community from X-ray crystallography was disbelief. They 
argued that the structure had been modeled using other proteins whose structures were previously 
determined by X-ray crystallography. But, with years of developments, such as higher magnetic 
field, cryoprobes, stability enhancements, and more complicated processing methods, nowadays, 
2 
 
NMR is a major structure determination technique complementary to X-ray crystallography.  The 
number of structure determined by NMR has been increasing steadily according to the Protein 
Data Bank statistics.  
  
 
Figure 1. The growth of protein structure solved by NMR according to RCSB protein data bank statistics. The number of 
protein structures solved by NMR grows steadily each year since 1986.Thre maroon bars represent the total structures 
accumulated every year while the blue bars indicate the structures solved by NMR each year. The inset is the enlarged 
portion of earlier years with extended scale for clarification. 
 Although comparing to X-ray crystallography, the number of total protein structures determined 
by NMR is still very small, NMR can provide other types of information that is hardly amenable 
by crystallography. For example, a wide range of time-scale dynamics can be investigated by 
different NMR techniques, from slow exchange by magnetization exchange spectroscopy 
(EXSY) to fast exchange by spin relaxation [3]. Chemical shift mapping can also provide 
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information on which part of the protein is interacting with substrates or ligands. This is very 
important for small molecule screening and optimization in drug discovery. Protein-protein or 
protein-ligand interactions play a key role in numerous cellular processes. However, even with 
defined structures for both partners in an interaction, co-crystallization of the complex might be 
difficult due to low affinity or local disorder. NMR can complement these interaction studies by 
chemical shift perturbation (CSP), paramagnetic relaxation enhancement (PRE), intermolecular 
NOE, H/D exchange rates and residual dipolar coupling.  
 
Another major advantage using NMR is that the sample flexibility. Not like protein 
crystallography, where the sample has to be crystalized and it is generally the bottleneck of 
applying crystallography for structure determination, NMR can be applied directly to protein in 
solutions or various solid forms such as powders, frozen solutions, microcrystals, gels or 
poteoliposomes [4-6]. This is extremely important for membrane proteins, which by nature is not 
soluble in aqueous solution and resist to crystallization.  
The membrane proteins consisted almost 30% of the whole protein in living cell [7] yet only 
about 500 structures are solved to date comparing to the total of over 100,000 structures in PDB. 
Membrane proteins are functionally important in cells as they connect the outside world and the 
interior of the cell. Numerous diseases are related to membrane proteins such as 
hyperinsulinemia, nephrogenic diabetes insipidus, congestive heart failure, liver cirrhosis, crystic 
fibrosis, lung edema, etc [8]. Solving the structures of these membrane proteins will guide the 
drug design for curing these diseases. To achieve this, two major problems in structure 
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determination of membrane proteins must be overcome. The first is to get sufficient amount 
membrane proteins expressed either in vivo or in vitro. The second is to apply the suitable 
technique to study the native state of the membrane protein. Recombinant protein expression has 
been used for decades and also readily applied to membrane proteins. However, they always tend 
to be expressed as inclusion bodies and require solubilization by denaturing conditions and then 
refold to its native structure. Detergents and/or lipids must be applied to make the protein soluble 
during the purification procedures. The final sample state is usually a mixture of proteins and 
detergents or lipids.  
Solid state NMR (ssNMR) is particularly suitable for studying samples like this. In solid samples, 
the nuclear spinning experience three major interactions: dipolar, chemical shift anisotropy, and 
quadrupolar interactions, which will cause very broad and featureless lines. By applying magic 
angle spinning (MAS) at 54.74° [9], these interactions will be average out leaving a much 
narrower spectrum. Normally, a high degree of 13C and 15N isotope labeling is required if 
molecular structure is to be investigated under MAS conditions. More importantly, the samples 
could be prepared in lipid bilayer, which is the very native environment as they are in vivo. Then 
the structure analysis can be preceded using a series of multi-dimensional correlation 
experiments. For example, the local dihedral angle constraints defined by backbone chemical 
shifts will provide the secondary structure information of the peptide [10]. The sequential 15N-15N 
distances can be used to refine the backbone topology [11]. The 3D structure will be finally 
determined if medium and long-range distance constraints can be derived from MAS NMR data. 




The ssNMR is still at the very young stage. From all 541 unique membrane proteins in database, 
only 42 are determined by ssNMR. But it does provide a bright future for membrane protein 
structure determination. The sample requirements are not as constrained as other methods and the 
protein will stay in its very native state (in lipid bilayer) during the experiment.  
In this dissertation, I will first briefly review the history of NMR spectroscopy in Chapter II. The 
basic principles and instrumentation of NMR will be introduced in Chapter III and IV, 
respectively. In Chapter V, I will show my work on a membrane protein PLIN1, which is the 
characteristic protein of lipid droplet located on the surface of this organelle. ssNMR was applied 
to try to decipher the structure of this protein. According to the NMR data, we proposed a 
membrane interacting model for this protein and this model was verified by both molecular 
dynamics simulation and experimental data. In Chapter VI, the soluble substrate binding domain 
of Mortalin was studied by solution NMR. We revealed its binding sites to a small anti-cancer 
molecule SHetA2. Through this interaction, SHetA2 competitively binds to Mortalin and release 
p53 from the Mortalin-p53 complex and the later enters cell nucleus, regulating cell apoptosis in 
tumor cells. According to our results, we also further proposed several SHetA2 analogs with 
greater binding affinities to Mortalin, which potentially will provide more stable interaction and 






History of NMR 
 
NMR originated from the ideas that spins and magnetic moments are the intrinsic properties of 
both electrons and nuclei. The first was established by several studies among which was the 
Stern-Gerlach experiment [12], where beams of atoms were separated in an inhomogeneous 
magnetic field according to the electron magnetic moment. Rabi etc [13] found later in 1933 that 
deflection of beams of hydrogen atoms though a homogeneous magnetic field subjected to radio 
frequency electromagnetic energy which was absorbed by the hydrogen atom in a very sharp 
frequency. This is the first time NMR was observed. Gorter [14] tried to detect the heat produced 
by the absorption of rf resonance energy and anomalous dispersion of the rf field to observe 
magnetic resonance in LiF. But the sample choice caused a fruitless attempt because of the long 
relaxation time of LiF.  Instead of trying to detect the heat or dispersion, Bloch took another way 
to detect the resonance.  According to physics law, he knew that the macroscopic magnetic 
moment would be rotated away from equilibrium position that was parallel to the applied 
magnetic field when the rf energy was applied.  This displacement of the magnetic moment 
would then precess about the applied magnetic field at a well-defined frequency. This frequency 
could be detected if a resonance coil was applied, which is in the rf range. Bloch, Hansen and 
Packard performed the experiment on bulk water, and the first NMR or nuclear induction as they 
called was born [15]. Purcell, Torrey and Pound [2] fortunately and successfully detected the 
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absorption of rf energy by the magnetic moment of proton in bulk paraffin because not like LiF, 
proton has a relatively much shorter relaxation time. Both Bloch and Purcell were awarded Noble 
prize in 1952 as they discovered NMR independently.  
In early days, NMR was not easy to perform as researchers had to build everything from scratch 
like magnets, coils, amplifiers. Russell Varian caught this opportunity and built the first 
commercial NMR spectrometer based on homogeneous magnet. The NMR technique developed 
rapidly thereafter as researchers can buy a basic NMR system rather than building everything 
from scratch. Bloembergen, Purcell and Pound [16] explained the concept of nuclear relaxation. 
They also stated the Brownian motion of liquids were the main reason that liquid NMR signals 
were magnitude narrower than solids because their nuclear magnetic dipole-dipole interaction 
averaged to zero. With the improvements of homogeneity of the magnet, more precise 
measurement on liquid were achievable. However, according to the theory, resonance of a 
particular atom should have a fixed frequency in a given magnetic field regardless of which 
chemical compounds the nucleus was in as shown in equation 1.  
 𝜔 = 𝛾𝐵0 (1) 
However, the experimental results showed variations in of the signal from 19F and 31P beyond 
error level. It was then postulated that this is caused by the electromagnetic properties of the 
surrounding electrons of the nucleus. These electrons provided the so-called shielding effect and 
it can be denoted as coefficient σ. So the modified equation 1 was:  




Where the value of σ depended on local environment of the nucleus, specifically the density and 
configuration of electrons. This shift was very annoying to physicists at first because they could 
not precisely measure the anticipated resonance frequency to determine the gyromagnetic ratio. 
However, it was later found to be the cornerstone to apply NMR to chemistry, as chemical shift.  
With the improvements of homogeneity and stability of magnetic field, 1H chemical shifts were 
determined because the shielding for proton was magnitude smaller than those for other nuclei. 
The demonstration of proton chemical shifts for ethanol in 1951 was the first time to show to the 
chemists what NMR spectroscopy could do to analytical chemistry [17]. Improvements in 
resolution further showed that even in the chemical shift resonance lines, there were a collection 
of resonance lines. And it was found that neighboring nuclei were responsible for these multiplets 
[18] and thus the idea of spin-spin coupling (scalar coupling) were conceived [19]. However, the 
lack of multiplets for OH group in ethanol drove the development of chemical exchange.  
Traditional continuous wave (cw) method varied the strength of the magnetic field of the 
spectrometer to find the resonance condition, which would show a deflection in the oscilloscope. 
However, this method was very time-consuming (several minutes per scan) and required high 
stability of the spectrometer during the entire acquiring period. Typical 1H resonance scan could 
take 5 to 10 minutes per scan, if longer time was needed, the random drift of the magnetic field 
might be the dominant factor. Due to the nature of NMR, the sensitivity was always a problem, 
especially when the sample was very diluted or limited amount, or even less sensitive nuclei were 
studied like carbon or nitrogen. Coherent time averaging was applied to deal with the problem 
because after N consecutive scans, the signal level could be N times stronger, while noise level 
only increased N1/2, thus increase the signal to noise ratio by a factor of N1/2. However, this is 
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sometimes not practically possible as increasing 100 times signal to noise ratio requires 10,000 
times of scans while each scan took 5 to 10 min to finish. Besides, most of the time only a small 
region of the whole cw spectrum was needed. The cw method was indeed time-consuming and 
inefficient. Bloch proposed the idea using PULSED rf excitation [1] as an alternative method 
rather than the traditional cw scan. It was first applied by mostly physicists to study systems with 
a single line, such as the broad line of a solid sample. It did not attract the chemists’ attentions 
mainly due to the complexity of the FID. Lowe and Norberg [20] showed the first time that the 
FID following an rf pulse could in principle be transformed to a spectrum that a normal cw scan 
would achieve. Ernst and Anderson [21] made it real in their publication. It was the development 
of small sized computer that made Fourier transform more real than on paper. The FT-NMR 
revolutionized the field. Not only the sensitivity was enhanced but also the timing window for the 
experiments are much shorter so that the dynamics and real-time reactions can be studied by 
NMR spectroscopy.  
Another Major breakthrough in NMR history is the development of 2D and multiple dimension 
spectroscopy. In 1971, Jeener originated the idea of 2D NMR spectroscopy, however, it was Ernst 
[22] that developed it into a practical method. In the 2D NMR spectroscopy, the nuclear 
magnetizations are allowed to precess during an initial time period, then various pulse sequences 
are applied to manipulate the coherence in this mixing period, and at last an FID is recorded. 
Applying Fourier transform on both dimension could transform the spectrum to be displayed on 
two orthogonal frequency dimensions. This method not only greatly increase the resolution 
comparing to 1 dimension spectrum, but also various interactions between different nuclei can be 
studied by applying different resonance frequencies. It is very powerful in assigning peaks in 
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complex spectra and studying interactions mediated by cross relaxation, chemical exchange or 
other physical factors [23]. 
Besides the wide application of NMR spectroscopy in organic chemistry, the developments of 
new powerful spectrometers, computer hardware, software, FT techniques, new multiple-
dimension methods, and line narrowing in solids, NMR spectroscopy finally can reach the far 
more complicated biological macromolecules. For small molecules, double resonance is the 
major tool to solve the chemical bonding schemes through the investigation of spin-coupling 
connectivity by selective decoupling. And the NOE measurements could give valuable 
information on internulcear distances. However, when such methods applied to proteins and other 
complex biopolymers, the complexity of the spectrum and the tedious acquisition time for 
hundreds of spectra lead to very limited success. The breakthrough was when COrrelated 
SpectroscopY (COSY) [24], which permitted the establishment of spin-coupling connectivities, 
and Nuclear Overhauser Enhancement SpectroscopY (NOESY), which allowed the relaxation 
effects to be used to estimate internuclear distances, were invented by Nagayama, Wüthrich, 
Bachmann and Ernst in 1977. Although the information obtained from COSY and NOESY could 
be extracted from a large number of sequential 1D spin-decoupling and NOE experiments, the 2D 
approach permits simultaneous measurements throughout the entire spectrum, increasing the 
efficiency by magnitudes. The enormous data acquired from the 3D experiments require fast 
speed and large capacity of modern computer as well as sophisticated software to support the 
Foureir transformation. The development of modern computer was essential for the application of 
NMR methods [25]. Solvent signal suppression is another major breakthrough in NMR history so 
that protein spectra can be acquired in water, permitting the NH resonances to be included in the 
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spin-coupling and NOE pathways. With this crucial addition of experiment, complete 3D protein 
structure can be determined solely on NMR spectra and the first structure of a 57-residue protein 
was published in 1985 by Wüthrich [26]. Therefore, an alternative method was finally established 
besides X-ray crystallography for biopolymers. 
The routes split into two at this point. In one direction, higher magnetic field and more 
sophisticated 3D methods were invented to get higher resolution thus more information can be 
obtained from the 3D spectra. In the other direction, some investigators were exploiting the speed 
and sensitivity of FT-NMR on small molecules in living cells, organisms or whole body. Bloch 
once joked about he was the first to apply in vivo study of NMR by putting his finger in the probe 
and observed water signals. However, water was the only signal they had at those years as they 
were so abundant in their spectra, little information could be obtained for other substances. Later, 
people were able to separate 31P signals from the bulk water [27]. Many groups succeeded 
growing tissues in the NMR tubes so that they can study cellular systems in living cells [28, 29]. 
Excised organs were perfused in the NMR tubes with nutrients so the metabolism could be 
investigated. Surface coils were developed to obtain signals from localized volumes near the skin 
of experimental animals. Depth pulses were designed to tailor rf excitation and define more 
precisely the volume of interest. The rf coils were even planted in animals to examine the internal 
organs. However, there is another way to use NMR non-invasively by applying magnetic field 
gradient. The Larmor equation became modified by the position thus the NMR frequency became 
a measurement of position. By repeating the NMR measurements in different directions, the 2D 
or even 3D image could be reconstructed by combining the spectra [30, 31]. And this became a 
well-known method called NMR imaging (MRI). Paul Lauterbur at Stony Brook University 
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generated the first MRI image of a living mouse in 1974. People immediately realized that NMR 
imaging had great potential for investigating human and animal anatomy since different water 
content and relaxation times in different tissues can be distinguished. The images of normal and 
pathological tissues can be readily obtained. In the late 1970s, Peter Mansfield, a physicist and 
professor at the University of Nottingham, England, developed a mathematical technique that 
would allow scans to take seconds rather than hours and produce clearer images than Lauterbur 
had. Damadian, along with Larry Minkoff and Michael Goldsmith, performed the first MRI body 
scan of a human being on July 3, 1977. Commercial development of MRI began ever since and 
quickly grew exponentially. Nowadays, almost every hospital installs MRI as a standard 
equipment. In 2003, Nobel Prize in Physiology or Medicine was awarded to Paul Lauterbur and 
Peter Mansfield for their "discoveries concerning magnetic resonance imaging". Although MRI is 
most commonly performed at 1.5 T, higher fields such as 3T are gaining more popularity because 
of their increased sensitivity and resolution. In research laboratories, human studies have been 
performed at up to 9.4 T and animal studies have been performed at up to 21.1T. 
NMR technology was quickly picked up by biologists and dramatic advances have been made in 
the application of high-resolution NMR spectroscopy in the determination of the 3D structure of 
large biopolymers, especially proteins. Earlier studies has been restricted to a molecular weight of 
10 kDa due to the complexity of the 2D spectra and the increased linewidth as the increasing 
molecular size.  The combination of isotope labeling (with 13C and 15N) and new experimental 
methods (transfer 1H magnetization through the peptide link from one amino acid residue to 
another to permit backbone sequential assignment) overcome the problem and 3D even 4D NMR 
spectra could be obtained. The precision of NMR methods is as good as that of X-Ray 
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crystallography while the NMR has the advantage of determining the structure in solution or in 







THE BAISCS OF NMR 
 
Section 1: Introduction 
Spin is an intrinsic property of elementary particles. Quarks possess spins, thus the protons and 
neutrons which are made of quarks have spins. The combination of protons and neutrons, aka, 
nucleus, also possesses spins. The spin of a nucleus can be shown as a nuclear spin angular 
momentum I,  
 |𝐈| = [𝐈 ⋅ 𝐈]1/2 = ħ[𝐼(𝐼 + 1)]1/2 
 
(3) 
Where I is the angular spin quantum number, ħ is the Planck’s constant (6.63×10-34 m2kg/s) 
divided by 2π. According to the angular spin quantum number I, all nuclei can be categorized into 
three groups as shown in Table 1, 1) nuclei with odd mass have half-integral spins. 2) nuclei with 
even mass but odd atomic number have integral spins. 3) nuclei with even mass and even atomic 
number have 0 spins. Since nuclear magnetic resonance rely on nuclear angular spin momentum. 
All nuclei in the last category are silent to NMR spectroscopy. Nuclei with a spin quantum 
number greater than ½ possess electric quadrupole momentum due to the non-spherical 





Mass number Atomic number 
Nuclear spin angular momentum 
quantum number I 
Odd Odd or Even ½, 3/2, 5/2, … 
Even Even 0 
Even Odd 1, 2, 3, … 
 
Typical nuclei that are most relevant to biological studies are listed in Table 2, among which the 
most interesting ones are 1H, 13C, 15N, 19F, 31P and 2H, where the 2H is an integer spin quantum 
number nucleus.  
Due to the quantum limits, when I2 ≡ I ⋅ I is defined, only one of the three Cartesian components 
can be specified. By convention, z direction component will be specified as  
 𝐼𝑧 = ħ𝑚 (4) 
, where m is the magnetic momentum quantum number and its value can be from (-I, -I+1 … I-1, 
I). Since Iz can only be 2I+1 discrete values and I is a constant, the spin angular momentum is 
quantized in space. It has 2I+1 quantum states corresponding to the 2I+1 values of Iz. In the 
absence of external field, all the quantum states have the same energy level and the spin angular 
momentum has no preferred orientation. The m also define a value called nuclear magnetic 
momentum, µ, which can be expressed by the nuclear spin angular momentum vector I, 




 μ𝑧 =  𝛾𝐼𝑧 = 𝛾ħ𝑚, (6) 
where γ is the gyromagnetic ratio. It is an intrinsic characteristic constant of the nucleus and it 
determines the receptivity of NMR spectroscopy. The γ value of some biologically important 
nuclei are shown in Table 2.  









ratio γ (107 







1H ½ 99.98 ─── 26.7522 100 600 
2H 1 1.5×10-2 2.87×10-3 4.1066 0.965 92.106 
3H ½ 0 ─── 28.5350 121 639.978 
7Li 3/2 92.58 -3.7×10-2 10.3976 29 233.178 
11B 3/2 80.42 4.1×10-2 8.5847 17 192.504 
13C ½ 1.108 ─── 6.7283 1.59 150.864 
14N 1 99.63 1.67×10-2 1.9338 0.101 43.344 
15N ½ 0.37 ─── -2.7126 0.104 60.798 
17O 5/2 3.7×10-2 -2.6×10-2 -3.6280 2.91 81.342 
19F ½ 100 ─── 25.1815 83 564.462 
23Na 3/2 100 0.10 7.0704 9.25 158.706 
25Mg 5/2 10.13 0.22 -1.6389 0.267 36.717 
31P ½ 100 ─── 10.8394 6.63 242.886 
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35Cl 3/2 75.53 -8.2×10-2 2.6242 0.47 58.788 
39K 3/2 93.1 5.5×10-2 1.2499 0.0508 28.002 
43Ca 7/2 0.145 -5×10-2 -1.8028 0.64 40.386 
51V 7/2 99.76 2.17×103 -5.2×10-2 38 157.734 
57Fe ½ 2.19 ─── 0.8687 3.37×10-3 19.386 
75As 3/2 100 0.29 4.5961 2.51 102.756 
77Se ½ 7.58 ─── 5.1214 0.693 114.402 
113Cd ½ 12.26 ─── -5.9609 0.109 133.092 
 
When there is an external magnetic field, the energies on each state is given by 
 𝐸 = −𝛍 ⋅ 𝐁, (7) 
 in which B is the magnetic field vector. The vector μ cannot collinear with the magnetic field B 
due to the face that |I| > Iz. So the minimum value of energy can be obtained when the projection 
of μ onto B is maximized. The energy of each states are quantized and proportional to their 
projections onto B. In NMR spectroscopy, external field are placed conveniently to the z 
directions, so the energy levels on each states are 
 𝐸𝑚 = −𝛾𝐼𝑧𝐵0 = −𝑚ħ𝛾𝐵0, (8) 
where B0 is the strength of the external magnetic field. So the projection of I onto z axis resulted 
in 2I+1 equally spaced energy levels, which are known as Zeeman splitting levels. It is a very 
important feature in NMR spectroscopy that the excited state has a lifetime on the order of 109 








where τ is the lifetime of the excited state and ω is the transition frequency from ground state to 
excited state. According to Heisenberg’s uncertainty principle, the long lifetime could result in an 
extremely narrow spectral lines in the NMR spectrum. So very subtle changes in the population 
differences between the two states can be readily detected and the long lifetime enable multi-
dimensional NMR spectroscopy where the magnetization is transferred from one nucleus to 
another before detection.5 
 
Figure 2 The nuclear spin quantum angular momentum I shown as the vector on the surface of the cone. It cannot be 
specified due to the quantum uncertainty of the x and y components. Its projection on the z axis are the quantized 
value for Iz. a) a spin ½ nucleus. b) a spin 1 nucleus. 
At equilibrium, according to Boltzmann distribution theory, the two energy states are unequally 
















where Nm is the population of the nuclei in the mth state, N is the total population of the spins, Em 
is the energy on the mth state, kB is the Boltzmann constant (1.3806488 × 10-23 m2 kg s-2 K-1) and 




























)/(2𝐼 + 1) (12) 
So, the population on each state depends on both the nucleus type (γ) and the applied external 
field strength (B0). The larger the external filed, the larger the energy gap between two adjacent 
states, the larger differences in population between the two states. The energy difference between 
mth and (m+1)th states is given by  
 𝛥𝐸 = ħ𝛾𝐵0 (13) 
It is directly proportional to the external magnetic field for a given nucleus. For a spin ½ nucleus, 
which is the most studied nuclear type in NMR, the electromagnetic frequency required to excited 
the spins from lower state or α state (m = +1/2) to upper state or β state (m = -1/2) is given by 




= 𝛾𝐵0/2𝜋 (15) 












For 1H nuclei in a 14.1 Tesla magnetic field at room temperature (~300 K), the population 
difference between the two states is in the order of 1 in 105. This tiny surplus from the lower 
energy state will be manipulated and detected as the NMR signal. Therefore, NMR is a relative 
insensitive spectroscopic technique comparing to visible or ultraviolet spectroscopy. This is also 
why building high magnetic field magnet is very critical in NMR development.  
 
Figure 3 The two Zeeman levels for a spin ½ nuclei. The nuclei in the lower energy state (α state for a positive γ 
nucleus) spin parallel with the external magnetic field, while those in the higher energy state (β state) spins anti-
parallel. As the external static magnetic field strength increases, the energy gap between the two states increases. 
There are two ways to view nuclear magnetic resonance, classical vector formalism and quantum 
mechanical density operator formalism.  
Section 2: The Bloch Equation 
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When there is an external magnetic field, the spins states are unequally populated, the excess 
population in the lower energy state give rise the individual magnetic moment μ and angular 
moment I.  The magnetic moments and angular moments from different nuclei in a given sample 
add up to a macroscopic bulk magnetic moment M and bulk angular moment J. At thermal 
equilibrium, the transverse components from the individual moments are not correlated and 
average out to 0. Both bulk magnetizations of the sample are along the same direction as the 
external field, z. So the bulk magnetization can be expressed as M = M0k, where k is the unit 
vector in z direction in a laboratory frame. 
Bloch formulated a simple semi classical vector model to describe the evolution of the bulk 
magnetic moment M over time. When an external magnetic field is present, the bulk magnetic 




= 𝐌(𝑡) × 𝐁(𝑡) (17) 
Multiply both sides by γ yields 
 𝑑𝐌(𝑡)
𝑑𝑡
= 𝐌(𝑡) × 𝛾𝐁(𝑡) (18) 
This expression shows how the bulk magnetic moment evolves with time and can be shown using 
a rotating frame with an angular velocity ω. Initially, the rotating frame is superimposed with the 
laboratory frame, all vectors are represented exactly the same. While the time differentials are 










)𝑙𝑎𝑏 + 𝐌(𝑡) × 𝜔 = 𝐌(𝑡) × (𝛾𝐁(𝑡) + 𝜔) (19) 
Comparing the two equations (17) and (18), it is shown that the expression of the rotation are 
identical for rotating frame and laboratory frame except that in rotating frame, the magnetic field 
is replaced with an effective magnetic field Beff: 
 𝐁eff = 𝐁(𝑡) + 𝜔/𝛾 (20) 
When ω = -γB(t), the effective field Beff is 0. The bulk magnetization M(t) is time independent in 
the rotating frame and it precesses around B(t) at a constant frequency ω = -γB in laboratory 
frame, which is known as the Larmor frequency. For an external static field B0, the bulk 
magnetization precesses around the main static field at its Larmor frequency ω0 = -γB0 which is 
exactly the same frequency required to excite the transitions between Zeeman levels.  
 
Figure 4 Classical view of the bulk magnetization M in an external static magnetic field B0. It precesses around the B 




Classical description only applies to isolated spins as each spin can be treated as a vector 
precessing around the main static magnetic field.  
As the bulk magnetization precesses, the varying magnetic field should create an induced 
electromotive force due to Faraday’s induction law. However, at thermal equilibrium, the bulk 
magnetization vector is collinear with the external magnetic field thus no induced current or emf 
can be detected due to the overwhelming external static magnetic field. But electromagnetic 
radiation can be represented as an oscillating magnetic field that interact with the bulk 
magnetization (as shown in Figure 5). With suitable frequency, normally in the radio frequency 
(rf) range for NMR, the bulk magnetization can be manipulated and the signal from the 
precession of the bulk magnetization can be readily detected.  
 
Figure 5 Electromagnetic waves can be treated as oscillating magnetic field. 
This short burst of radio frequency electromagnetic radiation is referred as a pulse. For an rf field 
linearly polarized to the x axis of the laboratory frame can be written as 
 𝐁𝑟𝑓(𝑡) = 2𝐵1 cos(𝜔𝑟𝑓 + 𝜙) 𝒊 (21) 
 = 𝐁1{cos(𝜔𝑟𝑓 + 𝜙)𝒊 + sin(𝜔𝑟𝑓 + 𝜙)𝒋} + 𝐁1{cos(𝜔𝑟𝑓 + 𝜙)𝒊 − sin(𝜔𝑟𝑓 + 𝜙)𝒋} (22) 
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where B1 is the amplitude of the applied field, ωrf is the angular frequency of the rf field or carrier 
frequency, ϕ is the phase of the field. As shown in equation (21), the rf pulse can be decomposed 
into two circularly polarized fields rotating in opposite directions about the z axis. The 
decomposition of the rf field at difference phases are shown in Figure 6.  
 
 
Figure 6 The illustration of the decomposition of radio frequency radiation into two circularly polarized fields rotating 
in opposite directions about the z axis. 
Only the field rotating in the same direction as the bulk magnetic moment will interact 
significantly with the bulk magnetization. The counter-rotating, non-resonant field only interact 
with the bulk magnetization to the order of (B1/2B0)2. Typically this value is very small and this 
interaction will be discarded. Thus, the simplification form of equation (21) will be 
 𝐁𝑟𝑓(𝑡) = 𝐵1{cos(𝜔𝑟𝑓 + 𝜙) 𝒊 + sin(𝜔𝑟𝑓 + 𝜙)𝒋} (23) 
In this case, where it is time dependent, the rotating frame transformation can be applied that 
makes the rotating frame rotates at angular frequency of ωrf about the z axis so that the equation 





= 𝐌𝑟(𝑡) × 𝛾𝐁𝑟 (24) 
The effective field Br in the rotating frame is given by 
 𝐁𝑟 = 𝐵1 cos 𝜙 𝒊
𝑟 + 𝐵1 sin 𝜙 𝒋
𝑟 + Ω/γ𝒌𝑟 (25) 
in which the Ω = -γB0 – ωrf = ω0 - ωrf is the offset, the difference between the effective field and 
resonance field. ΔB0 is known as the reduced static field affected by the B1 field and is equivalent 
to the z component of the effective filed, namely -Ω/γ. And the phase angle is defined such that 
for an rf field of fixed phase x, Bx = B1, By = 0. The magnitude of the effective field is given by  
  𝐵𝑟 = √(𝐵1)
2 + (Δ𝐵0)
2 = 𝐵1√1 + (tan 𝜃)
−2 (26) 






So, the direction of the effective field is defined by both θ, which is in turn defined by the 
strength of rf field B1, and the offset, the difference between the carrier frequency and Larmor 





Figure 7 The orientation of reduced static magnetic field B0, radio frequency field B1 and effective field Br in the 
rotating frame. 
The Mr(t) precesses around the effective filed Br with an angular frequency of ωr where  
 𝜔𝑟 = −𝛾𝐵𝑟 (28) 
If the carrier frequency ωrf is equal to the Larmor frequency ω0, then the offset Ω which is ω0 – ωrf 
will be 0. At this frequency, the impact of the external static magnetic field B0 is removed. The 
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effective field will be collinear with the applied field B1. This is a so called on-resonance. When 
on resonance, the bulk magnetization M(t)  precesses around the B1 field with a frequency 
defined by the B1 field, ωr = -γBr = -γB1 ≡ ω1.  
If the radio frequency field is turned on for a period time of τp, which is called the pulse width or 
pulse length. The effective flip angle α of M(t) from effective field is given by 
 𝛼 = 𝜔𝑟𝜏𝑝 = −𝛾𝐵
𝑟𝜏𝑝 (29) 
The precession of the bulk magnetization around the effective field in the rotating frame can be 
illustrated in Figure 8.  
 
Figure 8 The bulk magnetization precessing around the effective field in the rotating frame after a y phase radio 
frequency pulse is applied. a) Non-resonance case, where the effective field in in the y-z plane. b) On-resonance case, 
the effective magnetic field is collinear with the applied field in the y axis, the bulk magnetization is flipped 90° from B1 
and precess in the x-z plane. 
Section 3: Relaxation 
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The magnetization won’t stay in the x-y plane to spin forever after the pulse. However, it will 
slowly come from Zeeman splitting back to thermal equilibrium Boltzmann distribution. This 
process is defined as the spin-lattice relaxation or longitudinal relaxation. It is the mechanism by 
which the component of the magnetization vector along the direction of the static magnetic field 
reaches thermodynamic equilibrium with its surroundings (the "lattice"). R1 is defined to 
characterize the rate at which the longitudinal Mz component of the magnetization vector 
recovers towards its thermodynamic equilibrium, according to equation: 
 𝑑𝑀𝑧(𝑡)
𝑑𝑡
= 𝑅1[𝑀0 − 𝑀𝑧(𝑡)] (30) 
Where M0 is the magnetization at thermal equilibrium. Solving this equation gives 
 𝑀𝑧(𝑡) = 𝑀0 − [𝑀0 − 𝑀𝑧(0)]𝑒
−𝑅1𝑡 (31) 
Mz(0) is the magnetization at t = 0 where it is the beginning point of the decay process. So the 
longitudinal magnetization recovers to thermal equilibrium in the exponential fashion. In a 
special case, where Mz(0) = 0, which means the magnetization is flipped to the x-y plane after the 
rf pulse, the equation can be written as 
 𝑀𝑧(𝑡) = 𝑀0(1 − 𝑒
−𝑅1𝑡) (32) 
So we can define a time T1 = 1/R1, which means the time it takes for the longitudinal 
magnetization to recover approximately 63% of its initial value after being flipped into the 
magnetic transverse plane by a 90° radiofrequency pulse. 
Another process account for the NMR decay is the spin-spin relaxation, which the transverse 






= −𝑅2𝑀𝑥𝑦 (33) 
where R2 is defined as the spin-spin relaxation rate constant of the transverse components of the 
magnetization vector and its reverse T2, which is 1/R2, is the spin-spin relaxation time constant. 
Solving this equation would result in 
 𝑀𝑥𝑦 = 𝑀𝑥𝑦(0)e
−𝑅2𝑡 = 𝑀𝑥𝑦(0)𝑒
−𝑡/𝑇2 (34) 
So the T2 is defined as the transverse components of the magnetization decay to 37% of its initial 
value (t = 0) which is caused by the rf pulse. Different material have dramatically different T2s. 
For proton as an example, it can vary from sub milliseconds (in crystals) to seconds (in fluids). So 
it can be used as a detecting method to study the different components in a given sample. Putting 




= 𝛾[𝐌(𝑡) × 𝐁(𝑡)]𝑥 − 𝑅2𝑀𝑥(𝑡) (35) 
 𝑑𝑀𝑦(𝑡)
𝑑𝑡
= 𝛾[𝐌(𝑡) × 𝐁(𝑡)]𝑦 − 𝑅2𝑀𝑦(𝑡) (36) 
 𝑑𝑀𝑧(𝑡)
𝑑𝑡
= 𝛾[𝐌(𝑡) × 𝐁(𝑡)]𝑧 − 𝑅1[𝑀𝑧(𝑡) − 𝑀0] (37) 
where M(t) is the bulk magnetization, B(t) is the magnetic field experienced by the nuclei and it 
is equal to Bx(t)i+By(t)j+(B0-Ω/γ)k. Opening up the brackets would give 
 𝑑𝑀𝑥(𝑡)
𝑑𝑡
= 𝛾[𝑀𝑦(𝑡)𝐵𝑧(𝑡) − 𝑀𝑧(𝑡)𝐵𝑦(𝑡)] − 𝑅2𝑀𝑥(𝑡) (38) 
 𝑑𝑀𝑦(𝑡)
𝑑𝑡





= 𝛾[𝑀𝑥(𝑡)𝐵𝑦(𝑡) − 𝑀𝑦(𝑡)𝐵𝑥(𝑡)] − 𝑅1[𝑀𝑧(𝑡) − 𝑀0] (40) 
In the rotating frame where Br = B1cosϕ ir + B1sinϕ jr + Ω/γ kr, if neither B1 nor ϕ is time-
dependent and the pulse is only applied for a short time so that τp ≪ T1 or T2, these equations can 
be written as 
 𝑑𝑀𝑥(𝑡)
𝑑𝑡
= 𝛺𝑀𝑦(𝑡) − 𝜔1𝑠𝑖𝑛𝜙𝑀𝑧(𝑡) (41) 
 𝑑𝑀𝑦(𝑡)
𝑑𝑡
= 𝜔1𝑐𝑜𝑠𝜙𝑀𝑧(𝑡) − 𝛺𝑀𝑥(𝑡) (42) 
 𝑑𝑀𝑧(𝑡)
𝑑𝑡
= 𝜔1𝑠𝑖𝑛𝜙𝑀𝑥(𝑡) − 𝜔1𝑐𝑜𝑠𝜙𝑀𝑦(𝑡) (43) 












0 Ω −𝜔1 sin 𝜙
−Ω 0 𝜔1 cos 𝜙
𝜔1 sin 𝜙 −𝜔1 cos 𝜙 0
] 𝐌(𝑡) (44) 
The solution to this equation can be represented by a series of rotations of the magnetization 
M(0): 
 𝐌(𝜏𝑝) = 𝐑𝑧(𝜙)𝐑𝑦(𝜃)𝐑𝑧(𝛼)𝐑𝑦(−𝜃)𝐑𝑧(−𝜙)𝐌(0) (45) 
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cos 𝛽 0 sin 𝛽
0 1 0






cos 𝛽 − sin 𝛽 0
sin 𝛽 cos 𝛽 0
0 0 1
] (48) 
And rotation operator Ry(β) means the right hand rotation about y axis for an angle of β. In an 
ideal pulse NMR experiment, an on-resonance rf pulse of duration τp, strength B1, tilt angle θ = 
π/2, phase ϕ = π/2, the evolution of the magnetization after the pulse can be found by using the 
rotation operators as 
 





where α = -γBrτp, depending on the magnetic field strength and duration of the pulse. A maximum 
transverse magnetization can be generated with α = 90°. This rf pulse is called a 90° or a π/2 
pulse, which equalizes the population of both spins states for the spin ½ nuclei. And a 180° pulse 




Figure 9 The effects of on-resonance pulses. a) at thermal equilibrium, the two spin state are unequally populated 
according to Boltzmann distribution where N is the total number of spins and ΔN = NħγB0/(4kbT). b) after a 90° pulse, 
the population in both states are equal. c) after a 180° pulse, the population in the two states are reversed. 
The relaxations after the pulse can be detected during the so called acquisition time t which 
generates the signal called free induction decay (FID). This is the signal detected by the NMR 
spectrometer. Simplify the Bloch equation following the 90° pulse, Bxy = 0, Bz = B0, the free 
precession Bloch equation can be written as 
 𝑑𝑀𝑥(𝑡)
𝑑𝑡
= Ω𝑀𝑥(𝑡) − 𝑅2𝑀𝑥(𝑡) (50) 
 𝑑𝑀𝑦(𝑡)
𝑑𝑡
= −𝛺𝑀𝑦(𝑡) − 𝑅2𝑀𝑦(𝑡) (51) 
 𝑑𝑀𝑧(𝑡)
𝑑𝑡
= −𝑅1[(𝑀𝑧(𝑡) − 𝑀0] (52) 
The solution can be derived from these equations and they can be shown as 
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 𝑀𝑥(𝑡) = 𝑀0 sin 𝛼 cos(Ω𝑡) 𝑒
−𝑅2𝑡 (53) 
 𝑀𝑦(𝑡) = 𝑀0 sin 𝛼 sin(Ω𝑡) 𝑒
−𝑅2𝑡 (54) 
The combined complex notation of the solutions can be expressed as 
 𝑀+(𝑡) = 𝑀𝑥(𝑡) + 𝑖𝑀𝑦(𝑡) = 𝑀0 sin 𝛼 𝑒
𝑖Ω𝑡−𝑅2𝑡 (55) 
So the precession of the magnetization after the rf pulse is damped by the spin-spin relaxation 
exponential factor –R2t. For the on-resonance 90° pulse, where Ω = 0, sinα = 1, the signal is an 
exponentially decay curve. The off-resonance pulses, the decaying curve will be damped by the 




Figure 10 The on-resonance and off-resonance decay of the NMR signal. Solid line indicates the decay after an on-
resonance pulse, while dashed and dotted lines represent the signal of spins that are 150 Hz and 650 Hz off-resonance, 
respectively. All three resonances share the same T2 so they have the same envelope. 
Both the real and imaginary parts of the signal typically will be detected in the real NMR 
experiments with a proportional factor λ 
 𝑠+(𝑡) = 𝜆𝑀+(𝑡) (56) 





𝑆(𝜔) = ∫ 𝑠+(𝑡)𝑒−𝑖𝜔𝑡𝑑𝑡
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2 + (Ω − 𝜔)2
 (59) 
The real part represents an absorptive Lorentzian lineshape and the imaginary part is the 
corresponding dispersive Lorentzian lineshape. Typically the real part of the signal will be 
displayed in the frequency domain of NMR spectrum. 
Section 4: Chemical Shift 
As shown before, magnetization would precess around the external magnetic field with their 
respective Larmor Frequencies and the precession can be detected after it was flipped to the x-y 
plane by an rf pulse. However, if all same nuclei have the same resonance transition frequency, 
NMR spectroscopy would not much useful except telling which elements are in the sample. In 
reality, the observed resonance frequencies depend on the local environments of each individual 
nucleus as the motion of electrons induced by the external magnetic field generates a secondary 
magnetic field that cause a shielding effect on the target nucleus. This difference, defined as 
chemical shift, enables the possibilities to distinguish same nuclear type in different environments 
thus make NMR useful in detecting different structures of the molecule.  
The local field experienced by the nucleus with the shielding effect is given by 
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 𝐵 = (1 − 𝜎)𝐵0 (60) 
where σ represents the shielding effect of the nucleus spin. For an isotropic electron distribution, 









 When the electron density around the nucleus increases, the shielding effect decreases, leading to 
a lower resonance frequency.  
For an anisotropic electron distribution, which is in most cases, the shielding effect is described 







In the principle axis system (PAS), where the z axis coordinates with respect to the spin of 
nucleus. The electric field surrounding the nucleus can be described by the principle components 
of the chemical shift tensor σxx, σyy, σzz. The isotropic chemical shift tenser can be written as the 
average of the three principle components 
 
𝜎𝑖𝑠𝑜 =
𝜎𝑥𝑥 + 𝜎𝑦𝑦 + 𝜎𝑧𝑧
3
 (63) 
In solution, the rapid reorientation of the molecule caused by the collisions average out the 
chemical shift anisotropy that only a single isotropic chemical shift value can be observed. But in 
solids, the molecules will normally be oriented in all possible directions with respect to the 
external magnetic field and so a superposition of all possible chemical shifts is observed for each 
nucleus. Each magnetic moment of the system can be related for its PAS to the z axis by an angle, 
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θ, and its position in the x-y plane given by angle ϕ. The magnetization experienced at the 
nucleus on the basis of the PAS is given by 
 𝐵0
𝑃𝐴𝑆 = (sin 𝜃 cos 𝜙 , sin 𝜃 sin 𝜙 , cos 𝜃) (64) 
The chemical shift is written as 
 𝜔 = −𝜔0(𝜎𝑥𝑥 sin
2 𝜃 cos2 𝜙 + 𝜎𝑦𝑦 sin
2 𝜃 sin2 𝜙 + 𝜎𝑧𝑧 cos
2 𝜃) (65) 
This equation can be reduced to 
 




2 𝜃 − 1 + 𝜂 sin2 𝜃 cos 2𝜙) (66) 
in which the –ω0σiso is the isotropic chemical shift that can be observed in liquid state, Δ is the 
chemical shift anisotropy and η is the asymmetry parameter. 
This gives rise to broad peaks with a very characteristic shape as shown in Figure 11. In 
Haeberlen convention, the chemical shift anisotropy and asymmetry parameter are defined as 














Figure 11 Haeberlin convention of chemical shift anisotropy. The three principle components of the chemical shift 
tensors are shown as indicated in the dashed lines. Notice the huge spam of the chemical shift tensors in solid. 
The resonance frequency is directly proportional to the external magnetic field. So the difference 
in chemical shift between two resonances measured in frequency will also change when the 
external magnetic field changes. It is very inconvenient to compare the results of the same sample 
obtained from different spectrometers that have different magnet field strengths. Besides, any 
little drift from the external field would cause a different resonance frequency so the magnet has 
to be measured very precisely and it is almost impossible even in a single experiment, let alone 
from one measurement to another. So, in practical, the chemical shift is measured in parts per 
million (ppm) relative to a reference resonance signal of standard molecule instead of direct 





× 106 = (𝜎𝑟𝑒𝑓 − 𝜎) × 10
6 (70) 
The Ω and Ωref are the offsets of the sample and the reference, respectively, and ω0 is the Larmor 
frequency for this type of nucleus. Chemical shifts measure in this way are independent of the 
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external static magnetic field strength and signals from different spectrometers and experiments 
can be readily compared using ppm.  
 
Section 5 Limitation of classical model 
Classical vector model is very useful in displaying the bulk magnetization of isolated spins. 
However, it is very limited considering the interactions between spins. There are mainly two 
types of interactions between two spin nuclei: dipolar coupling and scalar (spin-spin) coupling. 
Dipolar coupling is extremely important in solids, however, in solution, it was averaged out to 0 
by the fast tumbling of the molecules. The splitting of the signals in the solution is due to the 
through bond coupling, which is mediated by the paired electrons forming chemical bond 
between the two nuclei. The interaction, named scalar coupling constant, is measured by nJab, 
where n is the number of chemical bonds separating the two nuclei and a, b indicate the two 
nuclei. Typically, the J coupling within 4 chemical bonds will be considered significant in NMR 
spectroscopy. 
J coupling constant will modify the energy level separated by the Zeeman splitting. Without J 
coupling, the two spin system for nuclei I and S can be shown by four wave functions 
 

























in which the first number in the parenthesis indicates the state of spin nucleus I, while the second 






























Given γI > γS > 0, the energy levels can be illustrated as shown in part a of Figure 11. The 
transition between states must obey the selection rule where Δm = ±1. So the transition can only 
happen between states 1-2, 1-3, 2-4 and 3-4. All other transitions are forbidden. The energy 
differences between these transitions are 
 |𝐸2 − 𝐸1| =  ℏ𝜔𝑆, |𝐸3 − 𝐸1| = ℏ𝜔𝐼 , |𝐸4 − 𝐸2| = ℏ𝜔𝐼 , |𝐸4 − 𝐸3| = ℏ𝜔𝑆 (73) 
Thus, the transition between energy states 1-2 and 3-4 share the same resonance frequency ωS, 
while the transition between energy states 1-3 and 2-4 share ωI. So a total of two resonance lines 
are predicted as shown in Figure 12.  
However, if the scalar coupling between nuclei I and S exists, the coupling constant JIS will 
modify each energy levels as (assuming weak coupling with 2π|JIS| << |ωI – ωS|) 
 𝐸(𝑚𝐼 , 𝑚𝑆) = 𝑚𝐼𝜔𝐼 + 𝑚𝑆𝜔𝑆 + 2𝜋𝑚𝐼𝑚𝑆𝐽𝐼𝑆 (74) 







































𝜋ℏ𝐽𝐼𝑆   
(75) 
And the transitions would still obey the selection rules such that only the transitions between 
energy states 1-2, 1-3, 3-4, 2-4 can happen. And the energy differences between these transitions 
are given by 
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 |𝐸2 − 𝐸1| = ℏ𝜔𝑆 + 𝜋ℏ𝐽𝐼𝑆, |𝐸3 − 𝐸1| = ℏ𝜔𝐼 + 𝜋ℏ𝐽𝐼𝑆,  
|𝐸4 − 𝐸3| = ℏ𝜔𝑆 − 𝜋ℏ𝐽𝐼𝑆, |𝐸4 − 𝐸2| = ℏ𝜔𝐼 − 𝜋ℏ𝐽𝐼𝑆 
(76) 
And the resonance lines would be shown as a modified resonance close to its original position 
 𝜔12 = 𝜔𝑆 + 𝜋𝐽𝐼𝑆, 𝜔13 = 𝜔𝐼 + 𝜋𝐽𝐼𝑆, 𝜔34 = 𝜔𝑆 − 𝜋𝐽𝐼𝑆, 𝜔24 = 𝜔𝐼 − 𝜋𝐽𝐼𝑆 (77) 
So, none of these transitions share the same resonance frequency but rather has their own distinct 
resonance lines with a modification term πJIS as shown in part d of Figure 11.  
The classical vector model would only predict two resonance lines for the two spins system. 
However, considering scalar coupling, there are actually 4 resonance spectral lines can be 
observed. So, strictly speaking, classical vector model and Bloch equations can be only applied to 
isolated spins which are independent magnetization vectors. A more complicated methods must 
be developed to describe and predict the behaviors of spins. This is where the quantum 





Figure 12 Energy levels of the two spin system (nuclei I and S) and the transition resonance frequency between states. 
Part a and c show the energy levels and transitions without scalar coupling. The transitions between energy levels 1-3 
and 2-4 share the same resonance frequency ωI while the transition between energy levels 1-2 and 3-4 share ωS. Part b 
and d show that when scalar coupling applies, the energy levels on each states are modified by the J coupling constant 
JIS, so the transition between those states are modified and centered on ωI or ωS but separated by 2πJIS. 
 
Section 6: Density matrix formalism 
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Also the classical vector model really helps in visualizing how the bulk magnetization precess, it 
is cannot deal with coupled spins. A more sophisticated system that not only follow the bulk 
magnetization, but rather a complete description of the evolution of the spin system at any time 
points is needed. That is the quantum mechanical density matrix formalism.  
Quantum mechanically, the two spin states for a spin ½ nucleus can be represented by two 
eigenkets 
 |𝛼⟩ = (
1
0




And of course the eigenbras would be as  
 ⟨𝛼|= (1 0), ⟨𝛽| = (0 1) (79) 
Any magnetization states ψ at any given time in the NMR experiment can be expressed in this 
vector space by the linear combination of these two basis kets with α and/or β coefficients as  































All these operators are Hermitian and satisfy the commutation relations as  
 [𝐼𝑥, 𝐼𝑦] = 𝑖𝐼𝑧, [𝐼𝑦, 𝐼𝑧] = 𝑖𝐼𝑥 , [𝐼𝑧, 𝐼𝑥] = 𝑖𝐼𝑦 (83) 









Where the Ĥ is the Hamiltonian of the system. This equation can be solved by separation of 





= −𝑖Ĥ𝜓𝜑(𝑡) (85) 
Where ψ is the time independent part of Ψ(t). The solution of it can finally be written as 
 Ψ(𝑡) = 𝜓𝑒−𝑖𝜔𝑡 (86) 
Where ω = E/ħ and the energy of the system E is defined by  
 
𝐸 = ∫ 𝜓∗Ĥ𝜓𝑑𝜏 (87) 
Thus, the expectation values of the magnetic moments can be solved by using these equations. 
For a spin ½ magnetic spin, the wavefunction in the static magnetic field can be written as the 
linear combination of the two basis states as 
 Ψ = 𝑐𝛼𝜓𝛼 + 𝑐𝛽𝜓𝛽 = 𝑎𝑒
−𝑖𝜔𝛼𝑡𝜓𝛼 + 𝑏𝑒
−𝑖𝜔𝛽𝑡𝜓𝛽 (88) 
Again, the ωα = Eα/ħ, ωβ = Eβ/ħ and a = |a|eiϕa, b = |b| eiϕb are phase complex numbers which also 
are normalized so that |a|2 + |b|2 = 1. The expected values of the spin ½ nucleus with μ = γI on 
each dimension would be given as 
 
〈𝜇𝑥〉 = ∫ Ψ


















{𝑒−𝑖[(𝜔𝛼−𝜔𝛽)𝑡+𝜙] + 𝑒𝑖[(𝜔𝛼−𝜔𝛽)𝑡+𝜙]} = 𝛾ℏ|𝑎||𝑏| cos(𝜔0 + 𝜙) 
 
〈𝜇𝑦〉 = ∫ Ψ















{𝑒−𝑖[(𝜔𝛼−𝜔𝛽)𝑡+𝜙] + 𝑒𝑖[(𝜔𝛼−𝜔𝛽)𝑡+𝜙]} = 𝛾ℏ|𝑎||𝑏| sin(𝜔0 + 𝜙) 
(90) 
 
〈𝜇𝑧〉 = ∫ Ψ















(|𝑎|2 − |𝑏|2) 
(91) 
where ω0 is the Larmor frequency and ϕ is a phase angle. These equations demonstrate the 
probabilities of each states of the spin which is exactly the same as showed in the classical vector 
model where the bulk magnetization precesses around the external magnetic field.   
If we defining the rotation operators as 
 𝐑𝑗(𝛼) = 𝑒
−𝑖𝛼𝐼𝑗, (92) 
then any rotation of the initial magnetization σ(0) can be written as 
 𝜎(𝑡) = 𝐑𝑗(𝛼)𝜎(0)𝐑𝑗
−1(𝛼), (93) 
where j is the direction and it can be x, y or z. Expanding the rotation operator in x direction in 
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= 𝐄 cos (
𝛼
2





Substituting the matrix representation of Ix into equation this equation results the matrix 



















𝑐 + 𝑖𝑠 0
0 𝑐 − 𝑖𝑠
) , 𝐑𝑧(𝛼) = (
𝑐 − 𝑖𝑠 0
0 𝑐 + 𝑖𝑠
). (97) 
Thus, any pulse with any flip angle can be derived using these pulse operators. For example, an x-





























2 − 𝑠2 2𝑖𝑐𝑠





cos 𝜋 𝑖 sin 𝜋














) = −𝐼𝑧 
(98) 
As we expected by classical vector model, this pulse rotates the magnetization from z direction to 
–z direction and reverse the population in the two states. If the angle is changed to 90° which is 

































) = −𝐼𝑦. (99) 
It is consistent with the classical vector model prediction, where the x-phase 90° pulse will rotate 
the magnetization from + z direction to – y axis. Now, if the pulse is removed, the magnetization 
– Iy will evolve freely guided by the time-independent Hamiltonian 
 Ĥ = (𝜔0 − 𝜔𝑟𝑓)𝐼𝑧 = Ω𝐼𝑧 (100) 
Applying this Hamiltonian onto – Iy would give  
 −𝑒−𝑖Ω𝑡𝐼𝑧𝐼𝑦𝑒
𝑖Ω𝑡𝐼𝑧 = 𝐼𝑥 sin(Ω𝑡) − 𝐼𝑦 cos(Ω𝑡), (101) 
which shows that the magnetization rotates from – y at t = 0 to + x at Ωt = π/2, to + y at Ωt = π 
and to – x at Ωt = 3π/2, same as predicted from classical vector model.  
Density matrix formalism is particularly useful for multi-spin system, where the classical vector 
model is hard to use in order to illustrate the evolution of multiple spins. For example, a two spin 
system consist of I and S, the free-precession Hamiltonian is given by  
 Ĥ = 𝜔𝐼𝐼𝑧 + 𝜔𝑆𝑆𝑧 + 2𝜋𝐽𝐼𝑆𝐈 ⋅ 𝐒, (102) 






With the defined strong scalar coupling parameter, the eigenfunctions can be found for a system 
of two coupled spins as 
 Ψ1 = |𝛼𝛼⟩, Ψ2 = cos 𝜃|𝛼𝛽⟩ + sin 𝜃 |𝛽𝛼⟩,  (104) 
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Ψ3 = cos 𝜃 |𝛽𝛼⟩ − sin 𝜃|𝛼𝛽⟩, Ψ4 = |𝛽𝛽⟩,  
The transformation matrix U that converts product basis to strong coupling basis is given by 
 
𝐔 = (
1 0 0 0
0 cos 𝜃 sin 𝜃 0
0 − sin 𝜃 cos 𝜃 0
0 0 0 1
) (105) 
For weak coupling, where θ = 0° and the wavefunctions of the two energy levels |αβ> and |βα> 
are independent, the weak Hamiltonian can be simplified as 
 Ĥ = 𝜔𝐼𝐼𝑧 + 𝜔𝑆𝑆𝑧 + 2𝜋𝐽𝐼𝑆𝐼𝑧𝑆𝑧 (106) 
And the transformation matrix U that converts product basis to weak coupling basis is given by 
 
𝑈 = (
𝑐 + 𝑖𝑠 0 0 0
0 𝑐 − 𝑖𝑠 0 0
0 0 𝑐 − 𝑖𝑠 0
0 0 0 𝑐 + 𝑖𝑠
), (107) 
where c = cos(πJISt/2) and s = sin(πJISt/2). 
Now, for a 2 spin ½ system I and S, the rotation operator for both spins can be derived by apply 
rotation operator on the individual spin and then multiply the result, for example, the rotation 
operator on the x axis applied on spin I can be written as: 
 







𝑐 0 −𝑖𝑠 0
0 𝑐 0 −𝑖𝑠
−𝑖𝑠 0 𝑐 0
0 −𝑖𝑠 0 𝑐
) (108) 











𝑐 −𝑖𝑠 0 0
−𝑖𝑠 𝑐 0 0
0 0 𝑐 −𝑖𝑠
0 0 −𝑖𝑠 𝑐
) (109) 
Now, multiply both could result the effect of the rotation operator on the weak coupling two spin 
system as 
 
𝐑𝑥(𝛼) = 𝐑𝑥(𝛼)[𝐼]𝐑𝑥(𝛼)[𝑆] = (
𝑐2 𝑖𝑐𝑠𝑢 𝑖𝑐𝑠𝑣 −𝑠2
𝑖𝑐𝑠𝑢 1 − 𝑠2𝑢2 −𝑠2𝑢𝑣 𝑖𝑐𝑠𝑢
𝑖𝑐𝑠𝑣 −𝑠2𝑢𝑣 1 − 𝑠2𝑣2 𝑖𝑐𝑠𝑣
−𝑠2 𝑖𝑐𝑠𝑢 𝑖𝑐𝑠𝑣 𝑐2
), (110) 
where c = cos(α/2), s = sin(α/2), u = cosθ + sinθ, v = cosθ – sinθ. This rotation operator for 2 spin 
system can be readily applied to any weakly coupled system. For example, an ideal 90° pulse 
with x-phase is applied to the two spin system. The initial state of the two spin system can be 
written as 















𝜔𝐼 + 𝜔𝑆 0 0 0
0 𝜔𝐼 − 𝜔𝑆 0 0
0 0 −𝜔𝐼 + 𝜔𝑆 0
0 0 0 −𝜔𝐼 − 𝜔𝑆
) 
(111) 
Apply the 90° x-phase pulse can be shown as 
 








1 −𝑖 −𝑖 −1
−𝑖 1 −1 −𝑖
−𝑖 −1 1 −𝑖
−1 −𝑖 −𝑖 1




𝜔𝐼 + 𝜔𝑆 0 0 0
0 𝜔𝐼 − 𝜔𝑆 0 0
0 0 −𝜔𝐼 + 𝜔𝑆 0
0 0 0 −𝜔𝐼 − 𝜔𝑆
) (
1 −𝑖 −𝑖 −1
−𝑖 1 −1 −𝑖
−𝑖 −1 1 −𝑖






0 𝑖𝜔𝑆 𝑖𝜔𝐼 0
−𝑖𝜔𝑆 0 0 𝑖𝜔𝐼
−𝑖𝜔𝐼 0 0 𝑖𝜔𝑆
0 −𝑖𝜔𝐼 −𝑖𝜔𝑆 0
) = −𝜔𝐼𝐼𝑦 − 𝜔𝑆𝑆𝑦 
As expected, an ideal 90° x-phase pulse rotate both magnetization into – y axis. Now, taking into 
account of the coupling constant JIS, executing the exponential operator 





0 0 0 −𝑒−𝑖(Ω𝐼+𝜋𝐽𝐼𝑆)𝑡 − 𝑒−𝑖(Ω𝑆+𝜋𝐽𝐼𝑆)𝑡
0 𝑒𝑖(Ω𝑆+𝜋𝐽𝐼𝑆)𝑡 𝑒𝑖(Ω𝑆+𝜋𝐽𝐼𝑆)𝑡 0
0 𝑒𝑖(Ω𝐼+𝜋𝐽𝐼𝑆)𝑡 𝑒𝑖(Ω𝐼+𝜋𝐽𝐼𝑆)𝑡 0
0 0 0 𝑒𝑖(Ω𝐼−𝜋𝐽𝐼𝑆)𝑡 + 𝑒𝑖(Ω𝑆−𝜋𝐽𝐼𝑆)𝑡
) (113) 
The observed magnetization will be proportional to the trace of this matrix with four terms: 
exp[i(ΩI+πJIS)t], exp[i(ΩI-πJIS)t], exp[i(ΩS+πJIS)t], exp[i(ΩS-πJIS)t]. So the final spectrum 









The basic NMR spectrometer consists of three main parts: the magnet, the console and the user 
interface computer. Each of these parts consist of some subsystems that work together to form 






Figure 13 Block diagram of a single channel NMR spectrometer. The main components includes the magnet with the 
sample probe, the transmitter and the receiver. The detailed description can be found in this each sections. 
 
Section 1: Magnet 
According to the NMR theory, the signal is directly proportional to the gyromagnetic ratio of the 
atom as well as the external magnetic field strength. Since we cannot control the gyromagnetic 
ratio of the atom as it is the intrinsic characteristic of the atom, the only variable we can 
manipulate is the magnetic field strength. Over years of innovation, nowadays, almost all magnets 
inside the NMR spectrometer are made of superconducting solenoid. To date, the highest 
commercially available spectrometer has a magnetic field of 23.5 Tesla with proton Larmor 
frequency of 1000 MHz, which is 500,000 times of the magnetic field of the earth. To achieve 
this kind of superconductivity, the superconducting solenoid is immersed in liquid helium at 4.2 
K which is surrounded by thermal radiation shield, a vacuum space, and then a dewar of liquid 
nitrogen to keep the minimum loss of liquid helium. The radiation shield which typically made of 
aluminum foil prevents the radiation of heat transfer. The vacuum prevents the conduction and 
convection of heat transfer. With such high insulation, the bore of the spectrometer, the 
shimming, excitation and detection coils as well as the sample can be placed at room temperature. 
Field homogeneity is very crucial to modern NMR spectrometers. When the superconducting 
coils is installed, the cryoshims will be adjusted to achieve a homogeneity field around the sample 
positions, typically less than 1 ppm inhomogeneity. After the superconducting coils starts to 
work, these cryoshims should not be changed. Upon daily uses, the room temperature shim coils, 
which are around the bore but outside the probe, should be adjusted to achieve better 
homogeneity with the sample inside the spectrometer bore. Present-generation magnets have field 
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homogeneity on the order of 1 ppb (part per billion). In addition to field homogeneity, stability of 
the magnet is also critical. It is affected by the inevitable decay of the magnetic field itself and 
external magnetic fields. In order to maintain the stability, a mini spectrometer called lock system 
was used parallel to the main spectrometer to monitor the locking frequency (typically 
deuterium). The lock system continuously measures the resonance frequency of the deuterium in 
the sample. If the resonance frequency of deuterium changes, the system will automatically 
correct it by changing the current in the shimming coil to maintain the lock frequency at the 
correct value.  
Section 2: Transmitter  
Radio frequency pulses that are used to excite spin states in NMR experiment are generated by 
transmitter. In order to achieve desired pulse width and frequency as long as correct phase and 
power level, the transmitter consist of several parts to execute these functions. The source of the 
radio frequency signal comes from the Frequency Synthesizer. It provides a stable continuous 
electromagnetic wave at desired frequency using a standard frequency reference. This source of 
continuous wave is gated by a transmitter controller that cut off the excess signals to create 
pulses. The transmitter controller also controls the phase, pulse power and gating switch. The 
amplitude is controlled by the computer controlled attenuator to desired level. The radio 
frequency pulse created by the gating is at low power. Before it is irradiated onto the sample, it 
will pass through the linear amplifier to obtain the pulse power that is required for a particular 
experiment. For the modern NMR spectrometer, each channel will equip one transmitter. For 
example, a triple-resonance spectrometer typically equips 3 transmitters for proton, carbon and 
nitrogen each in addition to the one used for locking. The power required on each channel is 
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directly proportional to their corresponding detecting nucleus gyromagnetic ratio. For proton, the 
power of the amplifier is typically at 50-100 W. For heteronucleus, the peak output power of the 
amplifier is on the order of hundreds of watts. 
Section 3: Duplexer  
The amplified radio frequency pulse coming from the transmitter will travel into the duplexer 
before it reaches the sample in the probe. The duplexer has two main functions. First, it block the 
strong rf pulse to get into the very sensitive signal detection circuitry. Second, when the NMR 
FID signal comes from the probe, it diverts it into the signal detection path rather than the path to 
the amplifier in the transmitter. This function is usually achieved by the arrangements of cables 
and diodes. But some duplexers use switches that can rapidly change between transmit mode and 
receive mode controlled by the pulse programmer. 
Section 4: Probe 
The probe is the most specialized part of the NMR spectrometer and is often the only part that 
needs to be changed from one experiment to another. It is a complex apparatus that holds the 
sample and is positioned coaxially in the bore of the magnet. Its main function is to place the 
sample into the homogeneous region of the magnetic field. The probe also equipped with a device 
that can rotate the sample in order to reduce the inhomogeneity of the sample so that narrower 
spectra can be achieved. The VT (variable temperature) control apparatus inside of the probe can 
also stabilize the temperature of the sample. In the probe, there are rf electronic circuits that serve 
as both the irradiation source of the rf waves and the detecting instruments for sub sequential rf 
emissions from the sample. Its design strongly affects the sensitivity of the spectrometer, the 
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homogeneity of the B1 rf field, the susceptibility to rf heating of the sample and the quality of the 
solvent suppression. For the simplest case, the rf circuit consists of a coil and two capacitors as 
shown in Figure 14.  
 
Figure 14 Schematic show of two types of probe coils: Parallel-series and Series-parallel LC circuits. Two capacitors, 
labeled as Ct and Cm, are adjustable for proper tuning and matching. The 50 Ω is the impedance of the circuit. 
The function of the coil as mentioned before, is twofold. First, during the pulse, the current 
coming from transmitter generates an oscillating magnetic field B1 to the sample. Second, when 
the pulse terminated, the coil detects the current created by the precession of the sample and send 
it to the duplexer and receiver. The coil is placed in such a way that the generated magnetic field 
is predominantly perpendicular to the main filed to create maximum flip angle during the pulse. 
In theory, two orthogonal coils detecting x-magnetization and y-magnetization should be used. 
However, it is hard to tune two orthogonal coils to the same frequency. Modern probes usually 
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recruit a single Helmholtz coil to achieve quadrature detection. The two capacitors in the circuit 
are labeled as matching capacitor and tuning capacitor. The matching capacitor couples the 
external signals into the probe circuit with maximum efficiency. The tuning capacitor which is 
parallel to the coil is to enhance the currents in the coil by electromagnetic resonance. These two 
capacitors are not independent, in a real experiment, both capacitors should be adjusted iteratively 
to optimize the NMR probe. The characteristics of the probe are given by two factors, quality 
factor Q and complex impedance Z, which are given by 
 𝑄 = 𝜔𝐿/𝑅 (114) 
 𝑍 = 𝑅 + 𝑖[𝜔𝐿 − 1/(𝜔𝐶)]. (115) 
The ω is the resonance frequency, L is the inductance of the coil, R is the resistance of the coil 
and C is the capacitance of the tuning capacitor.  
The signal to noise ratio (S/N) is a very important factor to be considered in designing an NMR 








√Δ𝑓[𝑇𝑐𝑅𝑐 + 𝑇𝑎(𝑅𝑐 + 𝑅𝑠) + 𝑇𝑠𝑅𝑠]
 (116) 
 The N is the total number of observed nuclei in the sample, γe and γd are the gyromagnetic ratios 
of the excited and detected nuclei, B0 is the external magnetic field strength, K is a factor related 
to coil design, Δf is the receiver bandwidth, T is temperature, R is resistance and the subscription 
of a, c, s represent amplifier, coil and sample. According to this equation, lowering the 
temperature of the coil and amplifier could potentially increase the signal to noise ratio. This is 
the idea that cryogenic probes are designed to operate coil at ~20 K to enhance the detection. 
Although different nuclei resonant at quite different frequencies, it is technically feasible to share 
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the same coil between separate tuned circuits, each operating on a different frequency. This is 
called multiple tuning. For example, for a triple-resonance 1H-13C-15N probe, it only contains two 
coils. One coil is double-tuned for 1H and 2H while the other is double-tuned to 13C and 15N. 
Section 5: Receiver 
The receiver consist of a preamplifier, a phase-sensitive detector and analog-to-digital converter. 
Immediately after the NMR signal is collected by the coils in the probe, the current will be passed 
through the duplexer first. The duplexer diverts the weak signal toward the preamplifier in the 
receiver to be scaled up to a more convenient voltage level. The noise figure of the preamplifier is 
very critical for the NMR spectrometer since it provides the initial stage of amplification of the 
signal. Later parts will unavoidably process the real NMR signal as well as the noises coming 
from the preamplifier. To minimize losses, the preamplifier is located as close to the probe as 
practical. In order to interpret the NMR data, the electromagnetic signal has to be converted to 
computerized digital form. This process in done by the analog-to-digital converter. However, the 
problem for NMR signal is it typically is in the range of several hundreds of megahertz which is 
too fast for current ADCs. It is very important to down-convert these frequencies to a more 
feasible level to the ADCs. The down-conversion is achieved by the phase-sensitive detector. It 
compares the NMR signal with a reference signal coming directly from the rf synthesizer. It 
detect the offset of the signal which is the difference between the NMR signal around Larmor 
frequency and the reference signal. This offset signal is less than 1 MHz (typically in kHz range) 
which is slow enough to be handled by the ADC. The detector also include audio filters designed 
to restrict the frequency bandwidth of the receiver to minimize the noise. The offset signal could 
be either positive or negative and it is confusing if only one channel is used in the detector. This 
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is why a phase-sensitive detector is required to detect the NMR signal to achieve quadrature 
detection. The signal is first split into two by a splitter. Each of the signal is mixed with the 
reference signal to achieve the offset audio frequency in the mixer. The two reference signals in 
the two mixer are 90° out of phase so that the resulting signals coming out of the mixers are one 
cosine modulated signal at offset frequency while the other is sine modulated signal at the same 
frequency. Combining the signals coming from both mixers could tell the differences between 
positive and negative offset since the signals that are 90° out of phase will be canceled out in the 
sine modulated signals but doubled in cosine modulated signals as shown in Figure 15. 
 
Figure 15 The quadrature detection. The time domain signals are shown on the left panel and the Fourier-transformed 
frequency domain signals are shown on the right panel. For simplification, the signal coming from a single coil is 
shown as cosine modulated cos(ω0t) in (a). After Fourier transformation, two peaks will arise in the frequency domain 
at ±ω0. In order to find the correct resonance frequency, the signal is split into two. The first will be mixed with a 
cos(ωreft) modulated reference signal as shown in (b). The other is mixed with a sin(ωreft) modulated reference signal 
as shown in (c). Their corresponding frequency domain spectra are shown in (h) and (i) which resonant at ±(ω0 – ωref) 
and ±(ω0 + ωref). The audio frequency filters will remove high frequency signals that are too far away from the Larmor 
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frequency. So the time domain signals after the filter are shown as in (d) and (e) and the corresponding frequency 
domain signals are shown in (j) and (k). In both, only the ±(ω0 – ωref) signal still remain. The signals from the two 
channels are now combined to give the correct resonance as shown in (f) and (l). 
So the NMR signal is in complex form with both real and imaginary part. After the phase-
sensitive detector, each part of the signal is connected to their own ADC. The ADC measures the 
voltage level of the input signal and convert it into a binary codes. This process is called 
digitization. The time separation between the sampling points of the ADC is called the sampling 
interval or dwell time. The inverse of the dwell time is the sampling bandwidth or spectral width.  
Depending on the experimental requirements, difference ADCs can be used. If a wide range of 
frequencies is required as typically do in solid-state NMR, the more rapid sampling is needed so 
comparing to solution NMR. The ADC used in solid state NMR is typically around 4 MHz while 
in solution NMR around 250 kHz. The resolution of the ADC depends on the bit size of the ADC. 
However, sampling speed will be reduced if a higher resolution is needed. As a compromise, a 
16-bit ADC is typically used in modern NMR spectrometer and it can represent numbers between 
-28 and 28-1 (-32,768 to 32,767). The magnitude of the analog signal must stay within the 
dynamic range of the ADC otherwise it is either not accurately read (too high) or being ignored 
(too small less than ½ bit).  
In many experiments, the phases of the rf pulses and the NMR signals are changed in a dynamic 
way. This allows one type of NMR signals to be distinguished from experimental artifacts or 
from different types of NMR signals. So a post-digitization phase shifter can be applied after the 
ADC. The digitized complex signal is passed into the phase shifter and multiplied by a complex 
phase factor before it is passed to the computer. This phase shift after the quadrature detection is 




Section 6: Data Processing 
Direct Fourier transformation of raw recorded NMR data rarely yield optimal frequency domain 
spectrum. Typically, some manipulations will be done before or after the Fourier transformation 
to maximize the information that can be withdrawn from the spectrum. 
Zero-filling is a technique that adding a series of zeroes into a data sequence prior to Fourier 
transformation. Fast Fourier transformation require the data points to be an integral power of 2. 
So, for a set of data points that is not an integral power of 2, zeroes will be automatically added to 
make up to the closest number that is an integral number power of 2. Beyond this, since the NMR 
signal comprises of both real and imaginary parts and the imaginary part is usually discard in 
multi dimension NMR spectroscopy, adding zeroes could compensate the loss of imaginary part 
as the imaginary part can be recovered from the real part. So if you have a set of 2n data points, 
adding another set of 2n zeroes could increase the spectral resolution. Additional zero fillings 
cannot gain additional information beyond this point. 
Linear prediction is another way to increase the resolution of the spectrum. This technique is very 
useful for long T2 relaxation atoms where the FID is truncated before fully decayed out. It is 
especially useful in multi-dimension NMR where the indirect domain typically don’t have enough 
time to completely decay. It is very important to use linear prediction for the indirect dimension 
to avoid sinc wiggles created by the truncated FID.  
Apodization is another very important technique to get a smooth satisfactory lineshape in the 
spectrum. The Apodization process multiply a filter function in the time domain before Fourier 
transformation. The time domain signal needs to be reduced to zero smoothly and a matched 
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function has to be applied to the FID prior Fourier transformation in order to achieve maximum 
signal-to-noise ratio. The matched function typically should have the same decay envelop as the 
FID signal. However, apodization results in more line broadening. There has to be a compromise 
between the apodization and line width. It is worth to notice that apodization does not increase 
the peak area under the Fourier transformed spectra. 
Phasing is crucial in NMR data processing. The digitized signal usually displays a frequency 
dependent phase error. This phase error can be corrected by applying a zero-order phase 
correction function and first-order phase correction function. Zero-order phase correction is 
frequency independent while the first-order phase correction contributes to a linearly frequency-
dependent phase. By adjusting both phase correction functions, a nicely absorption lineshape can 
be achieved throughout the whole spectra. Another phase error usually comes from a clipped FID 
where the first several data points exceed the dynamic range of the ADC. This can cause a 
baseline distortion in the spectrum called baseline roll. By adjusting the time between the 
observed pulse and the start of sampling, the distortion can be reduced. The most famous pulse 
sequence Hahn echo is usually applied in the 1H NMR spectroscopy to reduce baseline distortion. 






THE LIPID DROPLET PROTEIN PLIN1 
 
Section 1 Abstract 
Neutral lipid triglycerides, a main reserve for fat and energy, are stored in organelles called lipid 
droplets. The storage and release of triglycerides are actively regulated by several proteins 
specific to the droplet surface, one of which in insects is PLIN1. PLIN1 plays a key role in the 
activation of triglyceride hydrolysis upon phosphorylation. However, the structure of PLIN1 and 
its relation to functions remain elusive due to its insolubility and crystallization difficulty. Here 
we report the first solid-state NMR study on the Drosophila melanogaster PLIN1 in combination 
with molecular dynamics simulation to show the structural basis for its lipid droplet attachment. 
NMR spin diffusion experiments were consistent with the predicted membrane attachment motif 
of PLIN1. The data indicated that PLIN1 has close contact with the terminal methyl groups of the 
phospholipid acyl chains. Structure models for the membrane attachment motif were generated 
based on hydrophobicity analysis and NMR membrane insertion depth information. Simulated 
NMR spectra from a trans-model agreed with experimental spectra. In this model, lipids from the 
bottom leaflet were very close to the surface in the region enclosed by membrane attachment 
motif. This may imply that in real lipid droplet, triglyceride molecules might be brought close to 
the surface by the same mechanism, ready to leave the droplet in the event of lipolysis. 
Juxtaposition of triglyceride lipase structure to the trans-model suggested a possible interaction of 
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a conserved segment with the lipase by electrostatic interactions, opening the lipase lid to expose 
the catalytic center. To verify this binding model, the full-length protein was chopped into four 
segments without overlapping based on the bioinformatics analysis to study their individual 
binding affinity to the liposome by reconstitution. It was found that the 4 helices domain can be 
reconstituted into the liposome very efficiently, which agrees with the bioinformatics analysis and 
confirmed its lipid binding function. Interestingly, we found the PAT domain could also be 
reconstituted into the liposome, indicating its potential hydrophobic nature that could either be 
another lipid interaction domain or interact with the hydrophobic domain with the lipase. 
Section 2 Introduction 
Animals store most of excess energy in the form of neutral lipid triglycerides for later use as 
metabolic fuel. The hydrophobicity of triglycerides allows them to be densely packed into lipid 
droplets, providing an energy density 10 times that of hydrated proteins and carbohydrates [32]. 
The lipid droplets are composed of a triglyceride core surrounded by a monolayer of 
phospholipids and a variety of proteins [33] and can be readily visualized by light and electron 
microscopy [34-36]. The structure of lipid droplets is similar to that of lipoproteins but they still 
have very distinct features. Firstly, lipid droplets can be synthesized by all types of cells but 
lipoprotein synthesis are restricted to hepatocytes and enterocytes [37]. Secondly, lipid droplets 
can be considered as cell organelles as they mainly store lipids in place while lipoproteins are the 
intercellular carriers that transport lipid building blocks from one place to another. At last, 
lipoprotein only contains very limited types of proteins which enable them to execute the 
transportation function and reach target with limited interactions with the environment during the 
process. The proteome analysis of lipid droplet surface binding proteins reveals up to hundreds of 
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different proteins that has different functions in cell skeleton interaction, lipolysis and other 
metabolism processes [38-50]. More evidences [51-57] show that lipid droplet has direct contact 
with various organelles in the cell such as ER, mitochondria, peroxisomes, endosomes and other 
LDs. It is reported that LD originates from ER through a process called budding, where the 
DGAT on the ER surface synthesizes triglycerides into the intramembrane space between the two 
layers of ER membrane, resulting the outer membrane to bud out with the triglycerides inside [58, 
59]. Utilization of the stored triglycerides requires enzymatic breakdown (lipolysis) by lipases, 
while the surface layer of the droplet controls the accessibility of lipases to the stored 
triglycerides. Among the proteins surrounding the lipid droplet surface, proteins in the PAT 
family (named after three earliest members) have raised great interest in recent years. The PAT 
family consists of the mammalian Perilipin, ADRP, TIP47, S3-12, and OXPAT, as well as insect 
lipid storage droplet protein 1 (Lsd1) and 2 (Lsd2) [60]. Perilipin, ADRP, and Lsd1 constitutively 
attach to the lipid droplets, and they maintain fat storage and regulation of lipolysis. TIP47, S3-
12, OXPAT, and arguably Lsd2 bind reversibly to the droplets; hypothetically they are 
responsible for the packaging of newly synthesized triglycerides into lipid droplets [60]. A new 
nomenclature has been recently proposed for the mammalian PAT-family of proteins [61] as 
Perilipin to PLIN1, ADRP to PLIN2, TIP47 to PLIN3, S3-12 to PLIN4 and OXPAT to PLIN5. 
Accordingly, from now on we will refer Lsd1 and Lsd2 in Drosophila as PLIN1 and PLIN2, 
respectively. Mammals and insects share significant conservation in the molecular mechanism of 
lipid droplet metabolism, highlighting the tremendous potential of using genetic technical 
advantages of insects to discover novel features of lipid homeostasis [60, 62]. Studies of fruit fly 
models have established a correlation between triglyceride accumulation and the level of PLIN2 
expression [63]. It is shown that the protein composition is related to the size of the lipid droplet. 
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For small lipid droplets in Drosophila, both PLIN1 and PLIN2 can be found but only PLIN1 
shows up on large lipid droplets. PLIN1 is found exclusively associated with lipid droplets [64]. 
It dynamically interacts with lipid droplet to control access of lipase to triglycerides thus regulates 
the lipids homeostasis. In mammals, PLIN1 block the basal lipolysis but activates hormone 
sensitive lipase upon stimulation. In contrast to mouse perilipin, which protects triglycerides from 
hydrolysis [65, 66], depletion of Drosophila PLIN1 leads to adult-onset obesity [67] while 
overexpression of PLIN1 induces lipid droplet to shrink and aggregate [68]. PLIN1 serves as a 
lypolytic switch, which upon protein kinase A (PKA) mediated phosphorylation, promotes the 
activation of triglyceride lipolysis [69]. 
The association of these proteins on the surface of the lipid droplets is critical to their ability to 
properly regulate both storage and release of the triglycerides in the droplets. Despite the pressing 
need to understand the interaction between these proteins and the lipid droplets, progress has been 
hampered by the scarcity of three-dimensional structure information for these proteins. The first 
and so far the only structure determined was for the C-terminal TIP47 (residues 191-437) at 2.8 Å 
resolution using X-ray crystallography [70]. The structure consists of an α/β domain and a four-
helix bundle that resembles the receptor-binding domain of apolipoprotein E. The deep 
hydrophobic cleft between the α/β domain and the four-helix bundle is consistent with binding to 
hydrophobic proteins and small molecules, rather than to the extended phospholipid membrane. 
This C-terminus construct was selected from one dozen truncations for soluble protein 
expression. Regrettably, it does not have the N-terminal 11-mer helical repeats that are probably 
responsible for reversible binding to lipid membranes.  
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Meanwhile, in vitro systems have recently become available for structural and functional studies. 
Recombinant PLIN1 has been purified and reconstituted in lipid droplet-like particles [71, 72]. 
Using an in vitro system, it was shown that phosphorylation of PLIN1 enhances the triglyceride 
lipase activity, demonstrating the direct connection between PLIN1 phosphorylation and the 
activation of lipolysis [71]. Hypothetically, PLIN1 phosphorylation causes changes on the droplet 
surface, making the internal triglycerides more accessible to the lipase [69]. The ability to 
reconstitute PLIN1 in lipoprotein particles opens the possibility to design structural studies to 
advance our understanding of the mechanisms of lipolysis regulation. Nevertheless, these 
lipoprotein particles are too large (~20 nm diameter) for solution NMR studies, and they are very 
difficult if not impossible to form diffraction quality single crystals for crystallography studies.  
Fortunately, several other structural techniques could be applied to this type of samples. For 
example, topologies of lipoprotein complexes have been determined using solid-state NMR [73, 
74], fluorescence spectroscopy [75, 76] and electron paramagnetic resonance (EPR) [77]. Among 
these, solid-state NMR is particularly suitable to study these lipoprotein complexes because three-
dimensional structure details could be obtained [78-81]. Here we report both NMR experimental 
data and structural models that could be useful to advance our understanding of protein targeting 
to lipid droplet and the function of PLIN1. 
Section 3 Materials and Methods 
Isotopically enriched (13C, 15N) ISOGRO, 15NH4Cl and uniformly labeled 13C-glucose, were 
purchased from Sigma-Aldrich (St. Louis, MO). Lipid 1,2-dimyristoyl-sn-glycero-3-
phosphoglycerol (DMPG) was purchased from Avanti Polar Lipids (Alabaster, AL). Benzonase 
was purchased from EMD Millipore (Billerica, MA). His-beads were purchased from Bio-Rad 
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(Hercules, CA). Lysozyme was purchased from MP Biomedicals (Santa Ana, CA). Thrombin was 
purchase from Bio Pharm Laboratories (Alpine, UT). All restriction cleavage enzymes and DNA 
polymerase as well as ligase were purchased from New England Biolabs (Ipswich, MA).  
3.1 Protein expression and purification 
The over-expression of PLIN1 (CG10374, NP_732904.2) as a fusion protein with thioredoxin-
[His]6-S tag  was carried out as previously reported [71] with slight modifications to incorporate 
stable isotopes for NMR studies. In brief, Drosophila total mRNA was reverse transcribed using 
oligo-d(T)18-primer and the resulted cDNA was used as template to amplify the coding region of 
Lsd1 (CG10374, NP_732904.2) by PCR. The left and right primers were 5’ -
GACGACGACAAGATGGCAACTGCAACCAGCGGCAGTGGA and 5’ -
GAGGAGAAGCCCGGTCTAGACGCCGTTGATGTTATTGTG. The product was ligated into 
the vector pET-32 Ek/LIC that contains an N-terminal coding sequence for thioredoxin followed 
by His-Tag and S-Tag coding sequences. E. coli strain NovaBlue GigaSingles cells were 
transformed with the recombinant plasmid. Positive clones were confirmed by DNA sequencing. 
Plasmids extracted from these clones were transformed into E. coli Rosetta 2 cells for protein 
expression. Recombinant protein expression was induced with 1 mM IPTG when OD 600 reaches 
0.8. After 4 hours induction, bacteria were collected and resuspended in buffer (50 mM Tris, pH 
8, 1 mM EDTA, 100 mM NaCl, 1 mM PMSF) containing 0.3 mg/ml of lysozyme. After 30 min 
incubation, the preparation was centrifuged at 100,000g for 1 h. The fusion protein expressed as 
inclusion bodies as they can be found in the pellet. The inclusion bodies were resuspended in 0.1 
M sodium acetate pH 5, 5 mM MgCl2 and incubated with DNase I at 37 °C for 1 h. Sample was 
centrifuged (35,000g, 20 min) and the pellet was resuspended in 20 mM Tris, pH 7.5, 6 M urea, 
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0.3% octylglucoside, 0.5 M NaCl and vortexed at 40 °C for 15 min. After centrifugation (5000g, 
20 min) the procedure was repeated twice. The final pellet was resuspended in 20 mM Tris, pH 8, 
8 M urea, 10% Sarkosyl, 0.5 M NaCl, 1 mM DTT and sonicated in two steps for 1 min each time. 
The preparation was centrifuged (5000g, 20 min) and the pH adjusted to 7.5. Trx–Lsd1 stock 
solution (5 mg/ml) was kept in the freezer. Before usage the preparation was diluted to 0.5 mg/ml 
and dialyzed to a final concentration of 20 mM Tris, pH 7.5, 2 M urea, 0.10 M NaCl, 0.01% 
cholate. For 13C-15N double labeled protein expression, transformed E. coli Rosetta cells with the 
recombinant plasmid (pET32-CG10374) were grown in 200 mL Luria broth medium at 37 ºC 
until optical density 0.8 at 600 nm. The bacteria pellet was collected by centrifugation, and 
cultured in 1 liter M9 minimal medium containing reagents enriched with NMR-active stable 
isotopes (13C-glucose and 15NH4Cl). The medium was supplemented with properly labeled algae 
extracts (ISOGRO) to boost protein yield. When optical density reached 0.8, protein expression 
was induced by addition of 1 mM IPTG. After 6 hours, cells were harvested by centrifugation. 
Thioredoxin-Lsd1 fusion protein was purified essentially as previously described [71]. The final 
protein pellet was resuspended in 20 mM Tris, pH 8.0, 6 M Urea, 150 mM NaCl, 10 mM 
dithiothreitol and a solution of protein stock (1.7 mg/mL) was stored in the freezer.  
3.2 Protein reconstitution 
DPMG lipid powder was dissolved in organic solution Chloroform first. The solution was 
agitated in a round-bottom flask and let dry under N2 gas flow at 37 °C dry bath (phase transition 
temperature for DMPG is 23°C). The coated DMPG film at the bottom of the flask were kept 
under N2 gas flow for another 30 min before vacuum overnight. The thin DMPG film was 
dissolved in 20 mM Tris, pH 7.5, 2 M urea, 0.10 M NaCl to a target concentration of 6 mg/ml. 
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The dissolved lipids was vortexed vigorously for 30 s at RT and then applied to sonication at 30 
°C for 1 hour. DMPG liposomes (400 nmol) were mixed with 8 nmol of fusion protein (Trx–
Lsd1) in 20 mM Tris, pH 7.5, 2 M urea, 0.10 M NaCl, 0.01% cholate followed by exhaustive 
dialysis for 24 h against phosphate buffer (5 mM Na3PO4 pH 7.5, 20 mM NaCl) at 4 °C. After 
exhaustive dialysis, thioredoxin-PLIN1/DMPG complexes were brought to 60% (w/v) sucrose 
and subjected to ultracentrifugation in a sucrose density gradient (30 to 60 % (w/v)). The distinct 
white band floating at a density of 1.17g/ml was collected as a single fraction. Complexes were 
sedimented by ultracentrifugation in an aqueous buffer and resuspended in a buffer containing 5 
mM Na2HPO4, 0.15 M NaCl, 0.1% octylglucoside at pH 7.4 and incubated with thrombin (1 
unit/mg of protein) for 15 h at 4 ºC to cleave the thioredoxin-[His]6 tag. The cleaved tags were 
removed by passing the cleaved solution through a 10 kD cutoff membrane filter. After 
centrifugation, the pellet containing PLIN1/DMPG complex was washed with 5 mM phosphate 
buffer (pH 7.5) and excess of water was removed in the speed vac for 1 h. Based on proton NMR 
signal intensities, the sample contained about 35% wt of water. These complexes were previously 
reported to have apparent diameter of 20 nm [71], and they are likely small unilamellar vesicles 
(SUVs) [82]. The head groups of anionic lipids, such as DMPG, facilitate interaction with 
positively charged protein sidechain groups and they are important for membrane attachment of 
the protein. Neutral lipid DMPC was also tested, but it resulted in dramatic protein loss by 
sticking to the dialysis membranes and the centrifuge tubes. DMPG provided a cost effective way 
to obtain isotopically enriched PLIN1 lipoprotein complexes. 
3.3 NMR spectroscopy 
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All Solid-state NMR experiments were carried out on a 600 MHz Varian INOVA spectrometer 
and a triple resonance magic-angle spinning (MAS) probe with a 1.6 mm spin module. All 
spectra were acquired with a MAS rate at 13.3 kHz. For 13C 1D and 13C-13C 2D experiments, the 
proton 90º pulse was 2.2 μs, cross polarization (CP) contact time 0.7 ms, locking fields of 73 kHz 
on 1H and 80 kHz on 13C channels, 100 kHz two pulse phase modulation (TPPM) decoupling 
[83], and dipolar-assisted rotational resonance (DARR) recoupling [78, 84]. For proton spin 
diffusion experiment, the proton-detected NHH pulse sequence was modified from the CHH 
sequence [79] with MISSISSIPPI solvent suppression [80] and an additional T2 filter (300 μs) 
[81] to suppress signals from the less mobile protein molecule as shown in Figure 16. The CP 
locking fields were 73 and 60 kHz on 1H and 15N channels, respectively. Contact time for the first 
CP (1H to 15N) was 1 ms, and 0.6 ms for the second CP (15N to 1H). 
 
Figure 16 NHH spin diffusion pulse sequence modified from Luo et al. [79]. Proton polarization excited by the initial 
90º pulse is transferred to 15N by cross polarization and stored in the longitudinal direction by the first 15N 90º pulse. 
The remaining proton signals are suppressed by MISSISSIPPI, which employs homospoil gradients and saturation 
pulses; S =200 us, H=20, W=50 us [80]. The polarization is brought back to the transverse plane by the second 15N 
90º pulse and transferred back to 1H. Polarization propagates from protein protons to solvent (water and lipids) via 
spin-diffusion (tm). A T2-filter (F) is added to remove protein signals [81], leaving only polarization solvent protons to 
be detected. The π pulse is placed in the middle of F. Narrow and wide filled rectangles represent π/2 and π pulses, 





3.4 MD simulation and spectral simulation 
All MD simulations were performed on up to 600 processors on a linux cluster supercomputer 
using software GROMACS 4.5.5 and GROMOS96 54A7 force field combined with DMPG lipid 
interaction parameters with simple point charge-extended (SPCE) water model [85]. The non-
bonded van der Waals interactions were estimated using Lennard-Jones potential with cutoff 
value of 1.2 nm and the bonds were constrained by linear constraint solver (LINCS) algorithm 
[86]. Electrostatic forces and energies were calculated using Particle-Mesh Ewald (PME) 
summation algorithm with cutoff value of 1.2 nm too [87].  
Two equilibration phases, constant volume (NVT) and constant pressure (NPT) ensembles, were 
subsequently carried out, each with 1 fs time steps. In the first phase, the system was coupled to a 
strong temperature bath using V-rescale coupling [88] with temperature coupling constant of τT = 
0.1 ps to maintain system temperature at 300 K. In the second phase, Parrinello-Rahman pressure 
coupling [89] with coupling constant τP = 5.0 ps to maintain the pressure semi-isotropically at 1 
bar and a weak Nose-Hoover temperature coupling with a coupling constant τT = 0.5 ps [90-92] 
was used to ensure a true NPT ensemble. A total of 15 ns equilibration was followed by a 50 ns 
production run of molecular dynamics (MD) in 2 fs step size, during which temperature and 
pressure were maintained using weak coupling methods (Nose-Hoover with τT = 0.5 ps and 
Parrinello-Rahman with τP = 2 ps).  
For a given structure model, backbone and α-carbon chemical shifts were predicted by shiftX 
[93]. Based on these chemical shifts, 13C-13C 2D spectra were simulated by program peaks2ucsf 
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in the Sparky package (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, 
San Francisco) with assistance of a custom computer script. 
 
 
3.5 Trypsin protection assay and Mass spectrometry 
Trypsin was applied to the liposome with reconstituted protein in it to identify the binding 
domain of PLIN1 with the membrane. Trypsin was prepared by dissolving the powder to 1 mM 
HCl and stored at -20°C. The reconstituted protein on the liposome was incubated with trypsin at 
a ratio of 1 unit/mg protein at 37 °C overnight. The control experiment was done using buffer-
exchanged protein in 2M urea, 0.05% cholate with trypsin at the same enzyme to protein ratio. 
The cleaved sample was run on SDS-PAGE first and the protein bands are excised for mass 
spectrometry.  The sample was reduced, alkylated, and using another trypsin digestion before 
applied to HPLC-Mass spectrometry. Peptide mass fingerprints were used for database search 
using Mascot [94].  
3.6 Truncated PLIN1 mutant clone and reconstitution 
PLIN1 was truncated into 4 different pieces according to bioinformatics analysis without 
overlapping to study their individual lipid bilayer abilities. The full-length protein was separated 
into 4 different domains: the N-terminal PAT domain, the 4-Helix domain which shows lipid 
interactions, the R1 domain which is the segment in between of the first two, and the C-terminal 
domain R2. Since we don’t have empty pET-32 Ek/LIC in hand, the recombinant pET-32-FL-
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PLIN1 was used as both the PCR template and the final insertion plasmid. Primers designed to 
clone each domain are shown in Table 3. Since the full-length protein use LIC system as the 
recombination method, it does not disrupt the restriction cleavage sites on the plasmid. Double 
restriction cleavage was applied for cloning all the four segments into the vector. The vector with 
full-length PLIN1 was extracted from E. coli with ZyppyTM plasmid miniprep kit according to 
instructions. The extracted plasmid was used as template for the PCR amplification. The PCR 
was conducted in a 5 min 95 °C preparation followed by 45 cycles of 30 s 95 °C denature , 30 s 
45 °C annealing, 60 s 60 °C extension. The PCR product and the vector with full-length PLIN1 
were digested using Hind III and Kpn I as restriction cleavage enzymes, respectively. The ligation 
was performed with inserts: plasmids at the molar ratio of 3:1 at 37 °C for 2 hours. The ligated 
plasmid was transformed to E. coli DH5α for amplification. The extracted plasmids were later 
transformed to E. coli BL21 (DE3) for optimal protein expression. For soluble proteins, cell 
lysate was filtered against 0.2 μm filter to remove any remaining cell debris followed by passing 
through the Ni-NTA column (BioRad, Hercules, CA). For insoluble protein, cells were lysed 
followed by 36,000 g centrifugation. The pellet was tested on different buffers with 20 mM Tris, 
50 mM NaCl buffers at pH 8 with different additions in the following order: 1) 1% Triton X-100, 
2) 2M Urea, 3) 1% Triton X-100 + 2M urea, 4) 5% Sarkosyl, 5) 8M urea + 10% Sarkosyl. The 
reconstitution of these truncated mutant protein into the DMPG liposome was conducted the same 
way for the full-length protein. 
Section 4 Results and Discussions 
4.1 Spectra of 13C,15N-PLIN1 
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Initially, 13C 1D spectrum on 13C, 15N-uniformly labeled PLIN1 was performed to assess 
resolution and sensitivity, providing feedback for sample preparation process. The spectrum was 
acquired at several temperatures to assess cross polarization dynamics (Figure 17). Overall signal 
intensity increased by 30% when the temperature was lowered from -15 to -37 ºC, due to the fact 
that cross polarization from proton to 13C is more efficient when the dipolar coupling is strong in 
rigid molecules. The lipid methylene intensity increased by 50% instead, indicating that the 
mobility of acyl chains is reduced at lower temperatures than the protein, which presumably binds 
to the surface of the lipid membrane. From these 1D spectra, signals can be identified for 




Figure 17 13C cross polarization spectra of 13C,15N-PLIN1 lipoprotein complexes at different temperatures. Spectra 
were acquired on a 600 MHz instrument with the sample spinning at 13.3 kHz. For each spectrum 128 scans were 
accumulated. The data were apodized with 40 Hz line broadening. Calibrated sample temperature values are labeled 
in the figure. 
Several 13C-13C 2D correlation spectra were obtained to examine the chemical shift dispersion 
among amino acid types, and to analyze the secondary structures based on chemical shifts (the 
resonance position in a spectrum, in ppm unit) [95]. The 13C–13C 2D spectrum (Figure 18), 
acquired with 10 ms DARR mixing [78], shows peaks in all the expected locations. For example, 
the serine, threoine, alanine, and isoleucine correlations have been labeled in the Figure. 
Correlations observed in isolated regions of the spectrum (e.g., Ala C-C) provide a means to 
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performing analysis of secondary structure. Further analysis within the unique chemical shift 
ranges of various residue types showed that the C, Cand CO (carbonyl carbon) signals were 
observed with chemical shifts indicative of their secondary structure. For example, 47% of the 
Ala C-C correlations intensities (Figure 18 inset) are found in the area consistent with C and 
C chemical shifts characteristic of α-helical structures; 31% of the intensities are found in the 
area characteristic of turn or random coil structures; 22% in the area characteristic of β-sheet. 
These numbers are consistent with the analysis based on circular dichroism spectrum: 34% α-
helix, 16% β-sheets, 50% turns or random coil. Figure 18B shows the 13C–13C 2D spectrum with 
50 ms DARR mixing to create longer-range correlations. Among the many new peaks, the 
isoleucine C1-C2 and the inter-residue C-C correlations are also observed. Moreover, the 




Figure 18 13C-13C 2D correlation NMR spectra of the 13C, 15N-PLIN1 sample with 10 ms (A) and 50 ms (B) DARR mixing. 
The inset is the expansion of the alanine Cα-Cβ region, with three boxes marking the characteristic chemical shift 
ranges for the three types of secondary structure. Data were acquired on a 600 MHz instrument with the sample 
spinning at 13.3 kHz. Each spectrum took 42 hours, with 96 scans per row. Sample temperature was -37 °C.  
 
4.2 Membrane insertion by proton spin diffusion 
The attachment of PLIN1 on the surface of the lipid droplets is critical to its function in the 
activation of triglyceride hydrolysis. The four helices predicted in the central region have been 
hypothesized to be droplet targeting motifs based on their hydrophobicity (hydrophobic H6 and 
H8, amphipathic H7 and H9). To verify this hypothesis and to probe the depth of membrane 
insertion, NHH spin diffusion NMR experiment was performed at 45 ºC, higher than the gel to 
liquid-crystalline phase transition temperature (23 ºC) of DMPG (Figure 19A). This experimental 
temperature was chosen to give relatively sharp lipid methyl and methylene signals in proton 
spectra (Figure 19B). The proton resonances are assigned based on the published lipid NMR data. 
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Particularly, water resonates ca. 4.7 ppm, acyl chain methylene at ca. 1.3 ppm, and the terminal 
methyl groups of the acyl chains at ca. 0.8 ppm. In NHH spin diffusion experiments (Figure 16), 
proton polarization was first transferred to 15N by cross polarization and all remaining proton 
signals were then wiped off. The polarization was transferred back to protein proton and 
propagated to water and lipids via spin-diffusion (tm). The initial spectrum (tm = 0 ms, Fig. 19C) 
shows weak residue amide signals not completely removed by 300 s T2 filter; longer T2 delays 
hurt experimental sensitivity. The protein signal removal efficiency can be seen in Figure 20, 
where most of the signals were removed at τF = 600 μs. Nevertheless, the aliphatic region (0-4 
ppm) was free of interfering protein signals. The non-zero water signal likely originated from 
chemical exchange with lysine and arginine side chain amine protons, which could occur during 
15N to proton cross-polarization transfer. With increasing diffusion time (4 and 36 ms in Figure 




Figure 19 (A) DMPG molecule with proton designations. (B) Direct proton excitation spectrum on uniform 13C,15N-
PLIN1 reconstituted into DMPG vesicles at 45C. The amide region is magnified in the inset. (C) NHH spin diffusion 
spectra with diffusion time as indicated in the figure; 600 scans were acquired for each spectrum. 
The dependence of peak intensities on serial diffusion times, namely, spin diffusion buildup 
curves, are shown in Figure 21. The buildup rate of how fast a buildup curve reaches its plateau 
relates to the distance between the protein and water or lipid groups. The curve of the terminal 
CH3 groups of the acyl chains in Figure 21 exhibits a much faster buildup rate than water, 
indicating that a region of PLIN1 has close contact with the lipid acyl chains. This region of 
PLIN1 is buried in the middle of the bilayer in the native-like lipoprotein complexes; in the native 
lipid droplets, it very likely reaches the interface between the lipid monolayer and the triglyceride 
core. This deeply buried region should be critical to droplet attachment for PLIN1. Moreover, 
when PLIN1 is activated by phosphorylation, this region may be involved in opening the 




Figure 20 Suppression of protein signal by T2 filter in the NHH spin diffusion sequence. Eight scans were acquired for 
each spectrum. The diffusion time (tm) was zero. 
The CH2 buildup curve clearly shows a biphasic behavior, which can be decomposed into two 
exponential growth components. The fast component has a buildup rate similar to the CH3 curve, 
very likely arising from a region of PLIN1 in close contact with the acyl chain. The slow 
component may be attributed to long-range diffusion from cytosolic regions of PLIN1. The 
buildup rate of water is also relatively fast, indicating close contact of water with the protein. The 
rate is slower than the rates of CH2 and CH3 in close contact with the protein, due to a smaller 




Figure 21 Proton 1D spin diffusion data buildup curves as a function of mixing time. The CH2 and CH3 curves are also 
rescaled for easy comparison of buildup rates. The fast growing CH3 curve (down triangle) indicates a close contact 
between protein and the phospholipid acyl chain terminals, meaning that this part is deeply buried inside the lipid 
bilayer. While the CH2 group (up triangle) shows a clear biphasic behavior indicating that the there are two types of 
interactions with CH2 groups from the protein, possibly the one buried inside the bilayer and the one in the cytosol 
part. The experiment was performed at 45 ºC and data points were corrected for T1 relaxation. 
The proton spin diffusion data on water, CH2 and CH3 protons can provide a semi-quantitative 
evaluation of the protein regions located in different environments. The relative saturation 
intensities are roughly 85%, 8.5%, and 6.5% for water, CH2, and CH3 respectively, according to 
Figure 21 and taking into account that half of the CH2 intensity arises from close contact (Figure 
22). The sum of the latter two, 15%, represents percentage of the PLIN1 molecule anchored in the 
lipid membrane; this value is in very good agreement with the percentage (13%) of highly 
hydrophobic regions (residues 249 to 275 and 290 to 318) with regard to total number of amino 




Figure 22 Decomposition of CH2 buildup curve into two exponential growth components. The fast growth component 
was taken into account for calculating build up intensity from close contact with protein residues. 
 
4.3 model building 
So far, there is no structure or structure model for any PAT proteins bound to membrane. The 
conserved PAT domain of the PLIN1 is highly soluble and unlikely to participate in lipid 
interaction. No transmembrane domain was found in PLIN1 using HMMTOP server [96]. 
Bioinformatics analysis indicated that four predicted helices might participate in membrane 
targeting: hydrophobic helices H6 (249-261) and H8 (290-300) as well as amphipathic helices 
with high hydrophobic moment H7 (265-275) and H9 (301-318) [71]. The spin diffusion NMR 
experiments above corroborated this hypothesis. It is therefore interesting to build structural 
models for the membrane-binding domain, contained in the segment stretching from residue 249 
to 318. This segment also includes a highly conserved hydrophilic motif 282EPENQARP289 that 




Figure 23 The trans-model of PLIN1 membrane-anchoring motif. (A) Starting model constructed based on 
hydrophobicity of predicted helices (hydrophobic H6 and H8, amphipathic H7 and H9) and NMR membrane insertion 
information. (B) Top view of the model after 50 ns MD simulation in DMPG lipid bilayer. Alpha helices are shown in 
purple, coils in gray, turns in cyan, and 282EPENQARP289 motif in green. Lipids of the top leaflet are shown in orange, 
with the phosphorus shown in yellow sphere. (C) Side view of the model showing proximity between helices 6 and 8 
with the lipid methyl groups. The lipids from top layer are shown in orange lines while those from bottom layer in blue. 
(D) Juxtaposition of the triglyceride lipase structure (PDB 4TGL) to the PLIN1 model. PLIN1 is shown in black, with 
the 282EPENQARP289 motif shown in green, alpha carbon of E282 and E284 in red ball, alpha carbon of R288 in blue 
ball. TGL is shown in gray, with the opened lid (residues 82 to 96) in purple, the exposed catalytic center (S144, D203, 
H257) in CPK molecular models, alpha carbon of R86 in blue ball, and alpha carbon of D91 in red ball. 
Two models of the most probable membrane-binding motif (residues 249 to 318) containing 
predicted helices 6 to 9 [71] were manually constructed based on hydrophobicity distribution: 
trans-model in Figure 23A and cis-model in Figure 25A, respectively. The amphipathic helices 
H7 and H9 most likely lie in the membrane-cytosol interface. The loop between H7 and H8 is so 
placed as to expose the hydrophilic conserved 282EPENQARP289, which could be functionally 
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important. This requires the hydrophobic helices H6 and H8 to be placed parallel to the 
membrane surface. Had these two helices been aligned perpendicular to the membrane surface, 
this hydrophilic stretch would have been pulled into the membrane. First, the C trace was 
designed with assistance of Visual Molecular Dynamics (VMD) [97] and then the all-atom 
molecule structure was generated by Structural Alphabet based protein Backbone Builder from 
alpha Carbon trace (SABBAC) 1.3 [98]. The two starting models (shown in Fig. 5A and Fig. S4) 
were energy minimized in vacuum using GROMACS 4.5.5 [99] and then embedded in a bilayer 
containing 512 DMPG molecules, with the amphipathic helices right above the lipid phosphate 
groups. The atomic level coordinates and interaction parameters for well-equilibrated DMPG 
lipid bilayer [100] were downloaded from Lipidbook [101]. These models were put in periodic 
triclinic boxes, solvated with adequate water and counterions were added to obtain electrically 
neutral system. These systems were then taken through steepest descent energy minimization and 
found to converge to physically realistic minimum energy value with maximum force less than 
100 kJ/mol/nm. Then a total of 15 ns equilibration was performed, followed by a 50 ns 
production run of molecular dynamics (see details in Material and Methods). 
The final structure of the trans-model is shown in Figure 23 B and C. All helices were able to 
maintain the helical structures, but helices 7 and 8 slightly unwound. In the final structure, H6 
and H8 both have close contacts with the terminal methyl groups of the acyl chains from both 
leaflets, agreeing with the spin diffusion data (Figure 23C). The acyl chains of these lipids from 
the top leaflet wrapped around the helices to accommodate the perturbation caused by the protein. 
Such perturbation also caused the two leaflets to come close locally, allowing the terminal methyl 
groups from the bottom leaflet contact H6 and H8. Interestingly, lipids from the bottom leaflet 
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were getting very close to the surface in the region enclosed by the helices. This may imply that 
in real lipid droplet, triglyceride molecules might be brought close to the surface by the same 
mechanism, ready to leave the droplet in the event of lipolysis.  
In Figure 23D, the crystal structure of a fungus triglyceride lipase [102] is juxtaposed to the 
PLIN1 model. In this structure, the lid (82SSSIRNWIADLTFVP96, with residues 83 to 84 and 91 
to 95 as hinges and charged residues underlined) of the lipase is propped open by diethyl p-
nitrophenyl phosphate to expose a patch of hydrophobic area of 800 Å2 and the catalytic center 
residues S144, D203, H257. It is interesting that the footage of the lipase matches with PLIN1 
trans-model, and that the lipase lid has a similar orientation to the 282EPENQARP289 (charged 
residues underlined) motif of PLIN1. More importantly, two possible electrostatic interactions, 
one between the two glutamates (282E and 284E) on PLIN1 and 86R on the lipase and the other 
between 288R on PLIN1 and 91D on lipase, may be responsible to open the lipase lid in place of 
diethyl p-nitrophenyl phosphate. There is no structure of any Drosophila triglyceride lipase, 
however, sequence alignments show that several Drosophila fat body triglyceride lipases share 
conserved amino acids with the lid segment of the fungus lipase (Figure 24). The charged 
residues 86R and 91D of the fungus lipase have their counterparts in the Drosophila lipases (Figure 
24). Specifically, RLRNFTND of two isoforms of CG8552, which have been considered to be 
activated by PLIN1 in insects [60, 71], could facilitate electrostatic interaction for three pairs of 




Figure 24 Sequence alignments of fungus Rhizomucor miehei triglyceride lipase chain A (PDB ID: 4TGL) [102] with 
Drosophila melanogaster triglyceride lipases: two isoforms of CG8552 (NP_001188714.1 and NP_001188715.1) 
[103], CG11055 (NP_611463.1) [103], and CG8823 (NP_477331.1) [104]. The alignments were performed using 
program SIM [105]. 86R and 91D of the fungus lipase and corresponding charged residues in other proteins are 
underlined. 
The interaction between the two proteins may also cause reorganization of the PLIN1 structure 
and further perturbation to the local phospholipid molecules. Energy released from the 
electrostatic interactions could convert to mechanical energy, causing the lipase to push against 
H7 and H9 of PLIN1 (Figure 23D). This could results in an increased area for the region enclosed 
by the helices, creating a passage for the stored triglyceride molecules, which were already very 
close to the surface, to diffuse toward the catalytic center. The interaction of PLIN1 and 
triglyceride lipase is probably modulated by phosphorylation and Ca2+. Phosphorylation of PLIN1 
promotes lipase activity in hydrolyzing triglycerides stored inside the lipid droplet [69, 71] and 
Ca2+ is also an activator of lipolysis [106]. These facts suggest that phosphorylation and binding 
of Ca2+ could promote conformational changes affecting certain protein regions. These changes 
would affect the interaction of the protein with lipid, affecting the accessibility of the lipases to 
the triglyceride molecules, or the interaction of PLIN1 with lipases and/or other proteins required 
in the activation process. Thus, future studies of the structures of PLIN1 with and without Ca2+ 
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may identify structural changes that would explain the role of certain protein regions in the 
function of PLIN1. 
 
Figure 25 The cis-model of Lsd1 membrane-anchoring motif. (A) Starting model constructed based on hydrophobicity 
of predicted helices (hydrophobic H6 and H8, amphipathic H7 and H9) [71] and NMR membrane insertion 
information. (B) and (C) are two views of the model after 50 ns MD simulation in DMPG lipid bilayer. Alpha helices 
are shown in purple, 3-10 helices in blue, coils in gray, turns in cyan, and 282EPENQARP289 motif in green. Lipids are 
shown in orange, with the phosphorus shown in yellow sphere. Only one bilayer leaflet is shown since the protein does 
not penetrate into the other leaflet. (D) Juxtaposition of triglyceride lipase (PDB 4TGL) to Lsd1. Lsd1 is shown in 
black, with the 282EPENQARP289 motif shown in green, alpha carbon of E282 and E284 in red ball, alpha carbon of 
R288 in blue ball. TGL is shown in gray, with the opened lid (residues 82 to 96) in purple, the exposed catalytic center 
(S144, D203, H257) in CPK molecular models, alpha carbon of R86 in blue ball, and alpha carbon of D91 in red ball. 
The starting and final structures of the cis-model are shown in Figure 24. Helix 8 is completely 
unwound and helix 9 also significantly changed its structure. Neither the trans-model nor cis-
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model penetrates into the bottom layer of DMPG bilayer, in agreement with the proposed 
function of attaching the protein to the phospholipids monolayer covering the lipid droplet. 
 
 
4.4 Model verification by NMR data 
Backbone and -carbon chemical shifts were predicted from structures by program shiftX [93]. 
Based on these chemical shifts, 13C-13C 2D spectra were simulated and compared with 
experimental spectra (Figure 26 and 27). The simulated spectrum of trans-model agrees very well 
with experiments. The C-CO peaks of T262 and T291 (lower left corner of Figure 26A) do not 
have corresponding peaks in the experimental spectrum acquired with 10 ms DARR mixing, 
which is chosen for establishing short-range (1- and 2-bond) resonance correlations. Matching 
peaks are found for the experimental spectrum acquired with 50 ms DARR for long-range 
correlations (Figure 27B). These two threonine residues possibly undergo unfavorable dynamics, 
resulting in weaker dipolar coupling between C and CO. On the contrary, more unmatched 
peaks are found for the cis-model (Figure 26B and 27). The T291 and T 262 C-CO peak (lower 
left corner of Figure 26B) do not have matching peak even for the spectrum acquired with 50 ms 
DARR mixing (Figure 27B). A280, T300, and S303 are also mismatched. Therefore, the cis-




Figure 26 Verification of structure models by 13C-13C 2D data. The experimental spectrum (gray) was obtained with 10 
ms DARR mixing [78]. Simulated spectra (black) for the trans-model (A) and cis-model (B) only consist of C-C, C-
CO, and C-CO correlations, without other side chain carbons. 
 
Figure 27 Verification of structure models by 13C-13C 2D data with 10 ms (A) and 50 ms (B) DARR mixing. Simulated 
spectra are shown in blue and red for the trans-model and cis-model, respectively. The simulated spectra only consist 
of C-C, C-CO, and C-CO correlations, without other side chain carbons. Outlying resonances are labeled. 
 
4.5 Model verification by experimental data 
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The reconstituted PLIN1 protein in DMPG liposomes were subjected to protease digestion assay. 
The liposome were digested by trypsin at 37 °C overnight. High density Tricine gel was applied 
for separating these small peptides after digestion and revealed several small fragments around 1-
3 kD as shown in Figure 28. The gel bands were cut off and sent for mass spec analysis.  
 
Figure 28 High density Tricine gel to separate small peptide after trypsin digestion of PLIN1-liposome. The very right 
lane is the marker with their molecular weights labeled. The second lane from the right is the full-length PLIN1 
reconstituted into the liposome. Starting from the third lane from right to the very left, these eight lanes are the 
digested PLIN1-liposome supernatant and pellet fractions in alternative order. The best resolved bands (1 band from 
supernatant and 3 bands from pellet) as labeled in the figure were cut off for mass spec analysis. 
According to the gel, there are two major bands in the pellet, consistent with our prediction that 
two helices are deeply buried inside the liposome, with corresponding molecular weights around 
1.2 kD and 1.5 kD, respectively. The mass spec were performed on each band separated by the 
high density gel. A total of 36 unique peptides were identified in the full-length sample, 25 for 
P1, 27 for P2, 30 for P3 and 9 for supernatant.  
According to the bioinformatics analysis, the full-length PLIN1 protein was truncated into 4 
different segments to test the binding affinity to liposome, respectively. The four segments are 
named as the N-terminus PAT domain, R1 domain (the Region between PAT domain and 4-Helix 
domain), 4 Helix domain and R2 domain (Region after 4-Helix domain on the C terminus). All 
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segments were cloned into pET32 vector using primers shown in Table 3 and then transformed 
into E. coli for protein expression individually 
Table 3 Primers designed to amplify each truncated mutant of Lsd1 




5’ GT ATT GGT ACC ATG GCA 
ACT GCA ACC AGC GGC AGT 
G 
5’ GTT AGA AGC TTA TTT 
CAG AAC CGG ACG CAC 
CAG GTG 
HindIII, KpnI 
R1 5’ GT ATT GGT ACC CGC GCC 
GAT TCT GTC AAG CAA ATC 
5’ GTT AGA AGC TTA GAT 
GGT TCT TTG GGT AAG 
GCG GCG 
HindIII, KpnI 
4-Helix 5’ GT ATT GGT ACC GCA GAG 
GCT CGC GCC CTC AAA AAG 
5’ GTT AGA AGC TTA AAT 
ATG GTG GGC AAC CTC 
TGT TG 
HindIII, KpnI 
R2 5’ GT ATT GGT ACC ATC TAT 
ATC AAC CAC CGC ATC ATC 
5’ GTT AGA AGC TTA GTA 
GAC GCC GTT GAT GTT 
ATT GTG 
HindIII, KpnI 
Underline shows the complementary sequence to the template. Yellow means restriction cleavage 
sites. Red shows the added stop codon for the truncated recombination protein. 
The strategy for expressing the four segments was to use the pET32 with full-length PLIN1 gene 
as the template. The four segments were amplified by PCR as described in the Material and 
Methods. The amplified DNA were purified by agarose gel and subjected to digestion using Hind 
III and Kpn I as the restriction nucleases. The pET-32-fl-PLIN1 plasmids were also digested 
using the same nucleases. The digested product were purified again by gel and ligated by T4 
ligase. The ligation products were transformed into E. coli DH5α for amplification. The plasmids 
were confirmed correct by sequencing and transformed into E. coli BL21 (DE3) for protein 
expression. Protein expressions for all segments yield sufficient amount (> 10 mg/ml) for follow 
up tests. For R1 region, the recombinant proteins were mainly expressed as soluble form, 
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indicating they are probably not associated with membrane interaction. Interestingly, all segments 
have some expression in inclusion bodies, while 4-helix domain has some expression as soluble 
parts, indicating that solubility of recombinant proteins cannot directly reflect its actual natural 
hydrophobicity.  All proteins were purified the same way as full-length PLIN1. It is worth to 
mention that all these segments can be dissolved in 2 M urea buffer, which make them easier to 
be solubilized comparing to the full-length protein, which requires 8 M urea + 10% Sarkosyl. The 
solubilized proteins were buffer-exchanged to 0.01% cholate buffer after passing through Ni-
NTA column for purification. The purified proteins were subjected to DMPG liposome 
reconstitution assay as described before for full-length protein. The reconstituted liposomes were 
pelleted at 70,000 g centrifugation and washed with buffer before final centrifugation. Both the 
supernatant and pellet were subjected to SDS-PAGE analysis. 
 
Figure 29 SDS-PAGE results of the reconstitution of each segment from PLIN 1 protein. The protein were reconstituted 
into the liposome through a detergent-mediated method as described in the Material and Methods. After 
reconstitution, the liposomes were centrifuged down. The solution and pellet are separated and checked by SDS-PAGE. 
As shown in the figure, the PAT domain and 4-Helices domain can be integrated into the DMPG liposome, indicating 
their hydrophobicity. R1 and R2 domains cannot be integrated into the liposome, they are most likely the soluble parts 
of the protein. For PAT and 4H domain, the protein bands in the solution part means there are excess amount of 
protein in the sample preparation and some are still left in the solution after reconstitution. 
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As shown in Figure 29, it is interesting that not only 4-hliex domain can be reconstituted into the 
liposome, but the PAT domain also showed some ability to interact with the liposome. However, 
R1 and R2 domain have very low ability to be reconstituted into the liposome. It agrees with our 
NMR data and MD simulation model that 4-heix is the membrane interacting domain quite well. 
The PAT domain can also be reconstituted into the liposome. The bioinformatics analysis showed 
some hydrophobicity of this region, but no membrane interaction were predicted. It was reported 
that this domain was not required to bind to lipid droplet [60]. The GRAVY score of PAT domain 
gives -0.233 and PROSO (PROtein SOlubility) [107] shows very confused results because 
PROSO gives 0.557 which is just above the insolubility threshold 0.5, while PROSO II gives 
0.667 as soluble protein, the scores is also just above the threshold 0.6. The MEMEX 
(MEMbrane EXperimentability prediction) [108] gives a high insolubility probability of 1.0. All 
these results together showed the complexity of this domain. The hydrophobicity of PAT domain 
might contribute to the hydrophobic interactions with lipase. 
Section 5 Conclusion 
NMR spin diffusion experiments were consistent with the predicted membrane attachment motif 
of PLIN1, and they indicated that some regions of PLIN1 have a deep contact with the 
phospholipid acyl chains near the bilayer center. For a native lipid storage droplet that is covered 
by a lipid monolayer, PLIN1 could penetrate to the interface of the monolayer and the triglyceride 
core. Two structure models for the membrane attachment motif were generated based on 
hydrophobicity analysis and NMR membrane insertion depth information, followed by 
optimization in lipid environment. Both models consist of four membrane interacting elements 
that are roughly parallel to the membrane surface. Two amphipathic elements stay on the 
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membrane surface, and two hydrophobic elements are buried deeper. Simulated NMR spectra for 
the trans-model agreed with experimental spectra. Juxtaposition of the triglyceride lipase 
structure to the PLIN1 trans-model suggests a possible interaction of the conserved sequence 
(EPENQARP), which is on a long loop between lipid binding elements, with the lipase. The long 
loop could bind to the lipase lid domain by electrostatic interactions and open the lid to expose 
the catalytic center. Interaction with the lipase could also cause reorganization of the membrane 
attachment elements of PLIN1, leading to an increased area for the region enclosed by the 
membrane attachment motif. A passage may be created by this process for the stored triglyceride 
molecules, which are already very close to the surface due to perturbation by PLN1 attachment, 
to diffuse toward the catalytic center. Therefore, this structural model could help design future 






INTERACTION BETWEEN MORTALIN AND SHETA2 
 
Section 1 Abstract 
Retinoids are a group of small molecules that have been clinically proven with anti-cancer 
activities. They specifically induce cell apoptosis in malignant cancer cells but not normal tissue 
cells. However, the toxicity of this class always hinders its application in vivo. Heteroatom 
substitution on the ring generates a new class called heteroarotinoids showing dramatically 
reduced toxicity. Recent modification leads to a new novel class flexible heteroarotinoids (Flex-
Het) with a flexible linker between the heteroatom ring and aryl ring. Among these Flex-Hets, 
SHetA2 with thiourea linker is the most promising one, showing the greatest anti-cancer activity. 
Mass spec studies indicates SHetA2 binds to Mortalin, a heat shock protein 70 family member 
located in the mitochondria. It has been shown that in cancer cells, this protein is released to 
cytoplasm, sequestering p53 to block it from inducing apoptosis. In this study, we study the 
structure of the Mortalin substrate binding domain by solution NMR and show that it can interact 
with SHetA2. Chemical shift perturbation experiment demonstrates that the binding sites of 
Mortalin to SHetA2 are the substrate binding pocket. Docking of SHetA2 onto Mortalin by 
AutoDock result at least two favorable configurations, both are stabilized by 1) hydrophobic 
interactions of the hydrophobic heteroatom ring of SHetA2 with the hydrophobic substrate biding 
pocket of Mortalin; 2) the hydrogen bonds formed between the aryl ring NO2 group of SHetA2 
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and side chains amide groups from either R513 or K576. According to this binding model, we 
design several new molecules that can occupy both configurations of SHetA2 and test their 
binding affinity with AutoDock. We find one of the candidate shows a much higher binding 
affinity to the protein. These findings will guide future generations of anti-cancer Flex-Het 
design. 
Section 2 Introduction 
The study on retinoids can be originated back to the exploration of metabolism of Vitamin A 
[109]. It was found that Vitamin A was transformed to an activator, retinoic acid, which regulates 
RNA and protein expression in vivo [110-112]. Retinoids are natural and synthetic vitamin A 
analogs with at least one aromatic ring that function similar to steroid/thyroid hormone [113]. 
These retinoids activate the dimer retinoid acid receptors (RARs and RXRs) to regulate specific 
gene expressions [114]. The retinoids (especially all-trans retinoic acid and 13-cis-retinoic acid) 
have shown potential in the chemoprevention of a variety of different cancers in animal models 
and human cell lines [115-126]. However, the clinical application of retinoids are limited by their 
significant toxicity [127]. Lots of efforts have been expended to develop mimics of all trans-
retinoic acid with expectation of similar clinical effect but less toxicity. The search led to a novel 
group of compounds called heteroarotinoids (Hets) [128]. Heteroarotinoids are retinoid mimics 
containing an aryl ring and a heteroatom in the partially saturated ring. It has similar anti-cancer 
activity by activating RARs and induce gene regulation [129, 130]. The structure activity 
relationship studies found that increasing the specificity of heteroarotinoids for individual nuclear 
retinoic acid receptors could not separate the efficacy from the toxicity. The strategically insertion 
of heteroatom into the ring structure showed reduced toxicity in analogous of several retinoids 
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[129, 131, 132]. In particular, the toxicity of all-trans retinoic acid was reduced by 1,000-fold. 
Various Hets have been synthesized and tested on various cancer cell lines and several of them 
showed promising anti-cancer activities with reduced toxicity. Further exploration led to a group 
of compounds called Flexible Heteroarotinoids (Flex-Hets) where the linker between the 
heterocyclic ring and the aryl ring varied [132]. It was found that by introducing more flexible 
urea and thiourea linkers, the anti-cancer activity increased dramatically. Among all the Hets 
examined, the most potent one is called SHetA2 [133], the structure of which contains a thiourea 
group as the linker and Sulphur as the heteroatom in the heterocyclic ring. The official name is N-
(3,4-dihydro-2,2,4,4,-tetramethyl-2H-1-benzothiopyran-6-yl)-N’(4-nitrophenyl)thiourea. It 
showed the greatest level of efficacy and potency in the inhibition of a variety of different cancer 
cell lines while retaining low if not none level of toxicity on normal cells [132, 134-139]. SHetA2 
selectively inhibits cancer cell growth and induces cell apoptosis independent of the retinoic acid 
receptor pathway [140]. It was reported to suppress mitochondria permeability transition and 
enhance the cytochrome c release from mitochondria [134].  
SHetA2 showed strong activity against human head and neck cell carcinoma [130], ovarian 
cancer [141], lung cancer [142] and kidney cancer cells [143] by inducing apoptosis while 
exhibited very low toxicity and excellent discrimination between malignant and benign cells. Oral 
administration of SHetA2 in rats [144] showed inhibition of ovarian and kidney cancerous 
xenograft tumors growth at 10 mg/kg/day. It showed no genotoxicity by bacterial-Ames test, both 
in vivo and in vitro chromosomal aberration on mouse micronucleus [145]. The pre-clinic tests 
showed no significant toxicity at the highest given doses to rats and dogs for a 14 day period. In a 
28-day subchronic toxicity test, No Observed Adverse Effect Level (NOAEL) was achieved with 
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a dose of 1500 mg/kg/day on dogs [144]. Thus the therapeutic window for administrative safety 
with SHetA2 can be up to 150-fold above the effective dose in vivo. Pharmacokinetics studies 
[146] in mice revealed 10 mM concentration in plasma were achieved within 5 min. Oral 
bioavailability values were found to be 15% at 20 mg/kg and 19% at 60 mg/kg. The initial t1/2 of 
40 min and terminal t1/2 of 11.4 hours were obtained. Total body clearance was 1.81 μL/h/kg. All 
these data demonstrated the behaviors of SHetA2 is a favorable candidate for future development. 
Recently, a second generation of Flex-Hets were designed, synthesized and evaluated for 
biological activity on ovarian cancer cells [147].  But the most active candidate is still only at 
comparable level to SHetA2. SHetA2 so far is still the best anti-cancer Flex-Het. It effectively 
inhibits all the 60 human cancer cells lines in the National Cancer Institute (NCI) and was 
promoted into the RAPID (Rapid Access to Preventive Intervention Development, NSC 721689) 
program for preclinical studies as therapeutic and chemopreventive agent for cancer. 
It is well accepted that SHetA2 induces apoptosis in cancer cells. However, the detailed 
mechanism of the SHetA2 still remains elusive. One in vitro study showed that SHetA2 could 
reduce the level of Bcl-2 protein but not Bax and induce PARP-1 and caspase 3 cleavage to 
induce kidney cancer cell Caki-1 apoptosis [143]. It was also found that SHetA2 could repress the 
nuclear factor κB which regulates Bcl-2, cell differentiation as well as apoptosis. In both cancer 
and normal cells, SHetA2 induces G1 cell cycle arrest through reduction of cyclin D1. However, 
no directly evidence was found that SHetA2 directly interacts with these proteins. In order to 
search for direct interaction of SHetA2 with the protein, the small molecule was conjugated onto 
a magnetic sphere with slightly modification on the methyl group on the heteroatom ring [148]. 
The methyl group was converted to hydroxyl group so it can be linked to a long linker group on 
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the magnetic sphere. Both SHetA2 conjugated and non-conjugated spheres were incubated with 
human ovarian cancer cell A2780 whole cell protein extracts followed by washing with protein 
extraction buffer as well as excess amount of free SHetA2 molecules. The protein that was eluted 
from SHetA2-conjugated but not from non-conjugated spheres was subjected to mass 
spectrometry analysis. The protein Mortalin (HSPA9) was identified in both gel band excision 
QStar experiment and straight eluents analysis by Orbitrap. This is the first direct evidence that 
shows direct interaction of SHetA2 with protein in cell lysate. Further co-immunoprecipitation 
experiments confirmed the interaction between SHetA2 with Mortalin as SHetA2 disrupted the 
binding of Mortalin to p53 and p66shc inside cancer cells, where both meditate the mitochondria 
apoptosis pathway.  
Mortalin was first identified as a cellular mortality factor as comparing the mortal and immortal 
cells as it segregated with loss of immortality of serially passaged mouse embryonic fibroblasts 
cybrids [149, 150]. Immunostaining found this protein to be a pancytoplasmic protein in mortal 
cells. However, the antibody against Mortalin showed a distinct pattern which is perinuclear in 
immortal MEFs. It was found later that mouse possesses two Mortalins, MOT-1 (pancytoplasmic) 
and MOT-2 (perinuclear), with contrast functions but only two amino acids differences [151, 
152]. Overexpression of MOT-1 induces cellular senescence, while MOT-2 induces malignant 
transformation [153, 154]. Human only has one Mortalin homologue which functions as MOT-2 
in mouse [154, 155]. The encoding gene of human Mortalin is located on chromosome 5q31.1 
(gene name HSPA9B) [155, 156]. It was first called HMOT-2 until Mortalin was accepted. It is 
also known as p66mot-1, mtHsp70 (mitochondria stress-70 protein), GRP75 (glucose-regulating 
protein 75), HspA9 and PBP74 (peptide-binding protein 74). Human Mortalin is the mitochondria 
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heat shock protein 70 family member, but not induced by heat. It is a highly conserved molecular 
chaperone with high degree of identity with other Hsp70 family members as well as E. coli DnaK 
[157], S. cerevisiae SSClp [158], rat cytosolic Hsc70 [159] and endoplasmic reticulum (ER) Bip 
[160]. As the major mitochondria chaperone, the primary function of Mortalin is assisting 
mitochondria targeting protein folding and transportation through the mitochondria membrane 
with the help of Hsp60 [161, 162]. Although Mortalin mainly distributed in the mitochondria, it 
can also be found in cytoplasmic regions.  With different binding partners, it possesses diverse 
functions such as intracellular trafficking (Fibroblast Growth Factor-1, FGF-1) [163, 164], 
internalization of receptors (Interleukin-1 receptor type I) [165], protein modification 
(Mevalonate pyrophosphate decarboxylase MPD or MVD1 [166], voltage-dependent anion-
selective channel 1 VDAC-1 [167]) , iron-sulfur cluster biogenesis (Fe-S cluster [168] and J 
protein cochaperone), apoptosis suppression under mild stress response (p53, p66shc [169-172]) 
and immune responses (complement C8 and C9 [173, 174]). In particular, all Hsp70 family 
members have elevated expression levels in tumor cells, associating pre-malignant cell response 
to the selection process during tumorigenesis. These molecular chaperones contribute to the 
cellular immortalization due to the fact they buffer the conformational consequences of mutant 
proteins and help the cells survive through various stresses [175]. The mitochondria Hsp70 
member Mortalin was also found overexpressed in several tumor cell lines [176-178]. The 
interaction between Mortalin and p53 was first identified in the cytoplasm of tumor cells. 
Mortalin sequesters p53 in the cytoplasm fraction though physical contact and inhibits its normal 
transcriptional activation function which leads to uncontrolled cell proliferation, a hallmark of 
cancer cells [179-181]. And this interaction can be abrogated by MKT-077, a well-known 
inhibitor of Mortalin, which reactivates the wild-type p53 function. Overexpression of Mortalin 
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can reverse the p53-dependent suppression of centrosome duplication indicating the interaction 
was localized to centrosomes [182]. The physical contact of Mortalin and p53 happens during late 
G1, S and G2 phases of cell cycle while disassociation from them occurs during mitosis. This 
interaction has not been observed in normal cells, indicating that normal cell life expansion by 
Mortalin is p53-independent [161, 183]. 
Human Mortalin is a 74 kD protein with 679 amino acids. It shows higher similarity to bacterial 
homologue comparing to other Hsp70 family members, indicating it might descend from the 
precursor mitochondria which is an endosymbiont bacteria trapped inside of the cell. Due to the 
insolubility, no full-length Mortalin structure is available so far. A very recent study successfully 
expressed the full length protein as soluble form with the help of coexpression with the Hsp70-
escort protein1 (hHep1) [184]. However, only small angle X-ray scattering data was assessed and 
the low resolution surface shape was acquired. The ab initio model was superpositioined using 
two E.coli DnaK domains (NBD and SBD) as well as full-length DnaK. The superposition 
suggested an elongated shape of monomeric Mortalin comparing to DnaK. No detailed structure 
of the full-length protein have been revealed yet. Based on the evolutional conservation 
comparing to its Hsp70 family members, it is proposed that this protein should contain two 
domains just like the other Hsp70s. The two domains are ~42 kD Nucleotide-binding domain 
(NBD) and ~25 kD substrate-binding domain (SBD, or peptide-binding domain as PBD) with 
protease sensitive linker connecting them. The SBD can be further divided into two subdomains, 
the 13 kD β-sandwich domain (SBDβ) and the ~12 kD C-terminal helical domain (SBDα). They 
formed the so-called kettle model where NBD is the handle, SBD is the pot and the C-terminus is 
the lid. When NBD is bound to ADP, the two domains do not interact and it is a favorable 
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configuration for substrate to get into the substrate binding pocket inside the ‘pot’. Upon ADP-
ATP exchange, the SBDβ and linker region dock onto the NBD and induce a dramatic 
conformational change on the SBD through allosteric regulation, leading to the openness of the 
C-terminal ‘lid’ and release of substrate. So far, SBDβ together with the first two α-helices from 
SBDα and the whole NBD has been crystalized and their structure determined [185]. Using 
different deletion mutant recombinant protein, the co-immunoprecipitation assay presumed that 
Mortalin binds to p53 on the NBD, encompassing residues 253-282 although 105-538 segment 
didn’t show binding [186]. These data are still ambiguous if not wrong and deletion might cause 
partially structure unfold and result non-specific interactions. While in another study, it was 
shown that the purified SBD of Mortalin, instead of NBD, associated with p53 in a concentration-
dependent manor [187]. A mutation of V482F could abrogate the interaction which is also 
observed in DnaK, the bacteria homologue of Mortalin [188]. More interestingly, pre-incubation 
of Mortalin with a short peptide could greatly reduce its binding ability to p53. And the 
interaction between Mortalin and p53 can be abrogated by adding ATP if full-length protein was 
used [187]. All these evidences suggest that Mortalin binds to p53 through its substrate binding 
pocket on SBD. However, so far, no direct evidence such as co-crystallization showed the exact 
interacting domains between Mortalin and p53 yet.  
In this study, the structure of recombinant Mortalin SBD was accessed using solution NMR and it 
is found to be very similar to its crystal structure. We also used solution NMR to trace the 
chemical shifts of the purified recombinant Mortalin SBD protein titrated by SHetA2 with 
different molar ratios. Our results suggest that SHetA2 could physically bind to the substrate 
binding pocket of Mortalin. This could potentially disrupt the interaction of Mortalin with p53 
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due to the competitive inhibition thus leading to P53 translocation to nucleus and induce 
apoptosis. The docking experiments showed two main configurations of the interaction between 
SHetA2 and Mortalin which agreed with NMR data. According to these results, different SHetA2 
analogs were designed and tested with docking. It was shown that the small molecule that can 
occupy the space of both configurations of SHetA2 gave the most binding potential. This result 
would give further guide lines for improving the Flex-Het design and cancer drug development. 
Section 3 Materials and Methods 
Purified SHetA2 powder is kindly provided by Dr. Benbrook. The isotope (13C, 15N) enriched 
ISOGRO, 13C-glucose, 15NH4Cl are purchased from Sigma-Aldrich (St. Louis, MO). Ni-NTA 
purification kit is purchased from Bio-Rad (Hercules, CA). Lysozyme is purchased from MP 
Biomedicals (Santa Ana, CA). Thrombin is purchase from Bio Pharm Laboratories (Alpine, UT).  
3.1 Protein expression and purification 
Plasmid pET-52 with Mortalin SBD (AA#439-597) encoding gene was kindly provided by Dr. 
Benbrook. The plasmid was transformed into E. coli BL21 (DE3) for optimal protein expression. 
The stock cells were inoculated into LB medium and incubated at 37 °C until OD600 reaches 0.8. 
The cells were pelleted at 4000 g for 10 min and resuspended in 5 times volume of 13C-glucose, 
15NHCl4 minimum medium. The culture was incubated at 37 °C until OD600 reaches 0.8 again 
and then transferred to 20°C for induction. Final concentration of 1 mM IPTG was added to the 
culture and the cells are harvested after 20 hours induction by centrifugation. The cells are lysed 
by incubation with lysozyme at room temperature followed by sonication. The protein was found 
in the soluble part. The lysates were filtered against 0.2 μm pore size filter to remove any 
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remaining bacteria and then transferred to the Ni-NTA column for protein purification. The 
column was washed with 10 mM imidazole buffer and eluted with 1 M imidazole. The eluents 
were buffer exchanged to Tris-buffer and subsequently digested by HRV-3C protease to remove 
His-tag. The cleaved product were passed through Ni-NTA column again to remove the cleaved 
His-tag. The purity of the protein were examined by SDS-PAGE. Final concentration of the 
protein is 20 mg/ml and stored at 4 °C before use. 
3.2 NMR spectroscopy 
All NMR experiments were carried out on the Agilent INOVA 600 MHz spectrometer with the 
Nalorac 1H, 13C, 15N-labeled PFG triple resonance probe. VnmrJ software with Biopack suite of 
pulse programs was used to collect the data. All data were acquired at room temperature (25 °C). 
Backbone chemical shifts were assigned in a sequential manner using the following experiments: 
NHSQC, HNCA, HNcoCA, HNCACB, HNcoCACB, HNCO and HNcaCO. Data were processed 
using NMRPipe and analyzed using SPARKY. TALOS+ was used to calculate the secondary 
structure constraints and predict the secondary structure according to the backbone chemical 
shifts. 
3.3 SHetA2 titration 
SHetA2 was found to be water insoluble. DMSO was recruited as the solvent to dissolve SHetA2 
and the highest concentration we can have is 170 mg/ml. The DMSO dissolved SHetA2 was 
added into the 15N labeled protein solution sample at a molar ratio of protein to SHetA2 at 1:0.2, 
1:0.4, 1:0.6, 1:0.8, 1:1, 1:2, 1:4 and 1:8. A total of 10 mg protein in 400 μl buffer with 10% D2O 
was used for the titration experiment. For the first five titrations (1: 0.2 to 1: 1), 3.3 μl of 8.5 
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mg/ml SHetA2 dissolved in DMSO was added into the sample. The same volume of SHetA2 
solution with different concentrations added into the sample for the last three titrations (3.3 μl 
42.5 mg/ml to achieve 1: 2, 3.3 μl 85 mg/ml to achieve 1: 4 and 3.3 μl 170mg/ml to get to 1: 8). 
This would have the minimum effect on the protein concentration to ensure spectrum quality. As 
a control, the same amount of DMSO (solvent only without SHetA2) was tested on another batch 
of 15N labeled protein in parallel to the experiment and the same spectra with the same parameters 
were acquired. A quick proton 1D experiment was always checked before the NHSQC 2D 
experiment to ensure the sample is still in good condition and no significant loss of signals. The 
chemical shifts were assigned to each individual amino acids on both spectra. The chemical 
perturbation was calculated by using the difference between the SHetA2 titrated chemical shift 
minus the apo-state and the DMSO titrated chemical shifts minus the apo-state.  
 
𝛿 = √(𝛿𝑁𝑙 − 𝛿𝑁𝑠)
2
+ [10 × (𝛿𝐻𝑙 − 𝛿𝐻𝑠)]
2
, (117) 
where the δNl and δHl are the 15N and 1H chemical shift difference between the final SHetA2 
titration (protein: SHetA2 = 1:8) and apo-state. The δNs and δHs are the 15N and 1H chemical shift 
difference between the corresponding DMSO titration and apo-state. Two apo-state spectra were 
used to eliminate any variations between the two samples titrated in different experiments so that 
more accuracy would be expected. 
3.4 Protein assignments 
The peaks were first selected in NHSQC spectrum with a contour level that is sufficient to pick 
around 200 peaks (~168 residues after HRV-3C protease digestion). Using these 200 peaks as the 
reference, the peaks were selected from other 3D spectra (~400 peaks were selected from HNCA, 
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HNCO and HNcoCACB, ~ 200 peaks were selected from HNcoCA, HNcaCO and ~800 peaks 
were selected from HNCACB). The peak coordinates data along with intensity data were 
uploaded to the PINE server for auto-assignments followed by extensive labor for manual 
corrections. The finalized labeled spectra will be uploaded onto the BMRB. 
3.5 AutoDock docking simulation 
AutoDock was applied for predicting the interaction sites of small molecules (ligands) with 
Mortalin (macromolecule receptor). AutoDock 4.2 [189] suite was used for all the docking 
experiments and the results are first analyzed using AutoDock Tool (ADT) and then in VMD. For 
all small molecule ligand, the structure were generated using ChemSketchTM (Advanced 
Chemistry Development, Inc. ADC/Labs, Toronto, Canada) and converted to PDB file using 
OpenBabelGUI [190]. The ligand were set to rotate freely though single bonds to accommodate 
best conformation in space after docking. For protein, the crystal structure of Mortalin (3N8E) 
was downloaded from Protein Data Bank. The protein structure were prepared by ADT to obtain 
correct ionization and tautomeric states of amino acid residues. Only polar hydrogens were added 
back to the protein structure. Kollman united atom partial charges and salvation parameter were 
assigned. The docking grid box was selected to not only cover all the NMR perturbation sites to 
ensure the correct guide lines but also the surface of the protein to ensure binding specificity. 
AutoGrid was run first to prepare the coordinates system and then the Lamarckian Genetic 
Algorithm was sued with a population size of 150 and 25 million maximum evaluations for 10 




Section 4 Results and Discussion 
4.1 Recombinant Mortalin SBD expression and sample preparation 
The Mortalin SBD (AA 439-597) encoding gene was introduced into pET-52 vector through Nco 
I and BamH I double restriction cleavage sites with a customized stop codon right after the 
sequence. The recombinant protein was constructed with 10×His tag on the N terminus followed 
by a HRV-3C protease cleavage site (LEVLFQ/GP) and a linker (SGPASPR). The theoretical pI 
of the recombinant protein after treatment with HRV-3C protease is 5.31 and molecular weight 
(MW) is 18129.47. The plasmid was transformed into E. coli BL21 (DE3) for optimal expression. 
The cell was cultured in M9 minimum medium and induced by IPTG at 37 °C first, but it was 
found that no soluble protein was expressed at this temperature. This is probably caused by the 
fast expression of protein in high temperature and the folding process cannot complete in such a 
short time. The cell was then induced at a lower temperature (20 °C) overnight (20 hours). The 
recombinant protein was found in the soluble part in the cell lysates. The lysates were filtered to 
remove any remaining cells before loading onto the Ni-NTA column. The column was washed 
with three column volume of lysate buffer with 10 mM imidazole followed by 1 M imidazole 
elution. The eluent was buffer exchanged to Tris-buffer by passing through a 10 kD cutoff 
membrane.  The protein was digested by HRV-3C protease to remove the His tag on the N 
terminus. The cleaved 10 His tag was further removed by passing the protease-treated solution 
through Ni-NTA column again. The final sample was concentrated using the 10 kD cutoff 





Figure 30 SDS-PAGE of purified Mortalin and digestion by HRV 3C protease. The lane on the left is the marker proteins 
with molecular weight labeled. The four lanes in the middle are the purified protein through Ni-NTA. The very right 
lane shows the protein after treated with HRV-3C protease. After removal the His-tag, the molecular weight of the 
protein goes from 20.7 kD to 18.1 kD. 
 
4.2 Solution NMR of Mortalin SBD and backbone assignments 
The 450 μL sample was mixed with 50 μL D2O for locking signal before loading into the NMR 
tube. A standard 5 mm solution NMR tube was used for the experiment. First, an NSHQC 
spectrum was acquired to assess the quality of the sample. It was shown that the spectrum was 
well dispersed and proton resonance ranged from 7 ppm to 9.7 ppm, indicating the protein was 




Figure 31 1H-15N HSQC spectrum of the uniformly labeled Mortalin sample with assignments. All peaks expected from 
the recombinant protein are shown and labeled except the N-terminal Glycine 1 and Alanine 3 due to the unfavorable 
dynamics and they are in between two prolines. Prolines will not show up in the NH2D as they have no amide protons 
in the polypeptide. 
A sequential 3D backbone assignments experiments (HNCA, HNcoCA, HNCO, HNcaCO, 
HNCACB, HNcoCACB) were set to determine the structure of the protein. The peaks in NHSQC 
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were selected with such a contour level that approximately 200 peaks can be selected for the 168 
AA recombinant protein after cleavage. The resonances of the selected peaks in NHSQC were 
used as the guiding position in the 3D data set for peak selection. With proper contour levels, 
around 400 peaks were selected from HNCA, HNCO and HNcoCACB, ~ 200 peaks were 
selected from HNcoCA, HNcaCO and ~800 peaks were selected from HNCACB spectrum. The 
HNCA, HNcaCO and HNCACB provide the magnetization transfer information for both inter- 
and intra-residue, while HNcoCACB, HNcoCA and HNCO give only the intra-residue 
correlation. All these spectra are connected in such a way that each peak can find their partner in 
the other spectra to confirm the correct assignment. For example, normally two peaks from 
different carbon resonance frequencies but sharing the same proton and nitrogen frequency can be 
observed in the HNCA spectrum of residue i, one from residue i and the other from residue i-1. 
The peak from residue i can be found has a partner at the exact position in the HNcoCA spectrum 
of residue i+1 with a different nitrogen frequency, while the peak from residue i-1 has a partner in 
the HNcoCA spectrum of residue i itself. In this way, all resonance peaks from different spectra 




Figure 32 The backbone assignments example. The HNCACB and HNcoCACB spectra for residues 102 to 106 were 
displayed in each slices. Each HNCACB slice contains four peaks: the C and C from residue i and the C and C from 
residue i-1. Each HNcoCACB spectrum of residue i contains two peaks both from residue i-1. All there peaks can be 
correlated to form a backbone walk trace that connect all chemical shifts in a sequential manner. 
The peaks positions along with intensities data were exported and uploaded onto the PINE server 
2.0 [191] for auto assignments. The assigned data returned in high confidence for over 90% of the 
amino acids (Figure 33). The predicted structure directly from the assignments agrees very well 
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with the crystal structure (PDB ID: 3N8E), where multiple β-sheets structure distributed in the N-
terminus while two helices with a turn in between were found close to the C-terminus (Figure 
35). The structure has not been finalized since some adjustments and corrections would be made 
on the assignments. Part of second helix toward the C-terminus was unstructured potentially 
because the missing of C-terminus 3 helices bundle and the folding of this region is not complete. 
 
Figure 33 Assignments possibilities for each amino acids in Mortalin according to all 7 spectra uploaded onto the 
PINE server 2.0 including NHSQC, HNCA, HNcoCA, HNCO, HNcaCO, HNCACB, HNcoCACB. Green bars indicates 
100% confidence. Yellow-green indicates over 90% confidence. Cyan means over 80%, yellow means ambiguous 




Figure 34 Secondary structure probabilities predicted based on the chemical shifts directly assigned to each amino 
acids backbone. Green bar means α-helical while blue bar indicates β-sheet structure and the length of each bar 
represents possibility. 
The auto assigned spectra were examined in SPARKY program and manual adjustments and 
corrections were performed. The final corrected peak data were analyzed using TALOS+, a 
software which predicts the secondary structure based on ϕ/ψ location according to the NMR 
chemical shifts and amino acid type of the residue and its neighbors. The TALOS+ predicted 
secondary structure was illustrated in Figure 35. Again, it agrees very nicely with the crystal 
structure of the protein, with an eight β-sheets structure on the N-terminus and two connected α-
helices on the C-terminus. The second helix was partially unstructured on the carboxyl end and 
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this is because of the flexible C-terminus of the protein in the solution. While in the crystal 
environment, the C-termini of the two asymmetric units are in close contact, keeping the helices 
more stable comparing to the solution states.  
 
Figure 35 Secondary structure predicted by TALOS+ using the corrected Mortalin backbone chemical shifts. The 
structure predicted has a high overall confidence, especially in those structured regions. Both ends has a rather low 
confidence due to the fact that they are flexible regions in solution. Blue bars represent β-sheets structures while red 
bars represent α-helices and the lengths represent the probability. 
 
4.3 SHetA2 titration and chemical shift perturbation 
The interaction of protein with other agents such as ligand or other proteins can cause a local 
structure change or at least local electron density change. These changes can be readily detected 
by NMR spectroscopy. To investigate the interaction sites of Mortalin with SHetA2, chemical 
shift perturbation experiments were conducted. The SHetA2 was found to be water insoluble, so 
DMSO was used as the solvent for SHetA2. The highest concentration we got was 170 mg/ml. 
For the titration experiment, 500 μL of mg/ml protein sample was prepared and loaded into the 
NMR tube. NHSQC spectrum was acquired for the apo-state protein (without SHetA2). Then 33 
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μL SHetA2 solution was added into the sample tube to achieve the molar ratio of protein: SHetA2 
at 1:0.2. The NHSQC spectrum was acquired. The same procedure was repeated until the 
spectrum of the protein: SHetA2 ratio of 1:8 ratio was done. It was clear that some peaks are 
shifted as ligand added into the sample, as shown in Figure 36. 
 
Figure 36 Protein peak shifts caused by adding SHetA2. The protein backbone resonance peaks in the NHSQC 
spectrum were affected by SHetA2 titration. On the left, titration has little effect on these peaks. However, on the right, 
this V579 peak has a relative large position shift. Different colors indicating different molecular ratio of protein to 
SHetA2. (Red, apo-state 1:0; yellow, 1:0.4; green, 1:0.8, blue 1:2, purple, 1:8) 
In order to eliminate the disturbance of the solvent to the protein, a control experiment where the 
same amount of pure DMSO was added to the protein sample was performed and the NHSQC 
spectra on each step were recorded. All spectra from each titration steps were assigned using the 
apo-state a reference. The chemical shift perturbations on each protein to SHetA2 ratio were 
calculated as described in the Material and Methods. The chemical shift perturbation of each 
amino acid were shown in Figure 37. The top 10 most shifted peaks are L457, V471, S473, A475, 
G514, V515, I518, D572, K576, and E586. All these peaks together form a nice circle around the 
putative substrate binding pocket (as compared to the structure of HSP70 and DnaK) of the 
Mortalin SBD, indicating SHetA2 binding to this substrate binding cavity. This substrate binding 
pocket might be also the interaction domain of Mortalin with p53 protein. Due to competitive 
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inhibition, binding of SHetA2 disrupt the interaction between Mortalin and p53, releasing p53 
from the complex and the later translocate to the nucleus to induce apoptosis of the cancer cell. 
 
Figure 37 Chemical shift perturbation of SHetA2 on each amino acid residue of Mortalin. The height of the bar 
represents the relative chemical shift changes of SHetA2 titrated spectrum from DMSO titrated spectrum. The peaks 
from the final titration (protein: ligand=1:8) are used for the calculation. 
 
4.4 Multi-configurations of interactions between SHetA2 and Mortalin by AutoDock 
Mortalin has been shown to have the ability to sequester tumor suppress protein p53 in the 
cytoplasm region, inhibiting its ability to translocate into the nucleus and perform transcriptional 
regulation. In order to prove the SHetA2 can effectively bind to Mortalin and subsequently 
disrupt the interaction between Mortalin and p53, AutoDock was applied to study the interactions 
between SHetA2 and Mortalin. AutoDock is a suite of automatic docking tools that predict the 
interactions of ligand with biological macromolecules with known structure. It use Lamarckian 
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Generic Algorithm as well as empirical free energy scoring function to find the global minimum 
of the interaction energy between the ligand and receptor and explore all available degrees of 
freedom. The docking of SHetA2 was performed using the Mortalin crystal structure (PDB ID: 
3N8E) as the macromolecule. The resulted lowest energy states were shown in Figure. As guided 
by the titration data, the two lowest energy states were found with direct interactions with the 
NMR titration sites on Mortalin, with binding energy of -8.45 kcal/mol and -7.7 kcal/mol, 
respectively. For configuration 1 (-8.45 kcal/mol) as shown in Figure 38, the hydrophobic gem-
dimethyl group of SHetA2 was deeply inserted inside the substrate binding cavity of Mortalin, 
forming a strong hydrophobic interactions with methyl group on threonine T449. Additional 
hydrophobic interactions can also be found involving the hydrophobic end of SHetA2 and I447, 
V482, I484 and I518 deeply buried inside the substrate binding pocket of Mortalin. The two 
oxygen atoms on the nitro group of SHetA2 form hydrogen bonds with the two amidine protons 
from arginine (R513) to stabilize the hydrophilic end of the molecule (Table 4). The C-terminal 
E586 potentially interacts with R513 in the apo-state, adding of SHetA2 disrupts this interaction 
and E586 showed a large chemical shift change in the perturbation chart. In addition, another 
hydrogen bond can be found between carboxyl group of the serine (S473) and the NH group on 
the thiourea linker, and S473 also showed a large chemical shift change in the perturbation plot. 
For configuration 2 (- 7.7 kcal/mol) as shown in Figure 39, one of the oxygen atom from the nitro 
group on SHetA2 forms hydrogen bond with the amine group on K576, which is the most 
perturbed residue in the protein (Table 4 and Figure 37). Additional hydrogen bonds can be found 
between the NH groups on the SHetA2 thiourea linker with glutamine (Q470). The hydrophobic 
ring structure is barely inside the substrate binding pocket, in close proximity with S473 and 
V471. Some of these sites can be directly seen from the chemical shift perturbation chart such as 
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S473, V471, R576 and I518. However, some of them are not directly reflected by the perturbation 
chart potentially because the local secondary structure are not affected much and their backbone 
chemical shifts are not as sensitive. For these amino acids, side chain NMR experiments like 
NOESY could give more accurate perturbation effects. 
Table 4 The hydrogen bond interactions between the Mortalin (PDB 3N8E) and two configurations of SHetA2 
Protein configuration Hydrogen bond Bond length Binding energy 
Mortalin 1 R(513) N-H … O = N 2.84 Å -8.45 kcal/mol 
(3N8E)  R(513) N-H’ … O’ = N 2.74 Å  
  S(437) C = O … H-N 3.13 Å  
 2 K(576) N-H …O = N 2.64 Å -7.7 kcal.mol 
  Q(470) C = O … H-N 2.80 Å  
  Q(470) C = O … H-N’ 2.92 Å  
 
 
Figure 38 The first configuration of SHetA2 binding to Mortalin with binding energy of -8.45 kcal/mol. A) The nitro 
group on SHetA2 form hydrogen bonds with R513 from Mortalin. One of the NH group on the thiourea linker also 
forms hydrogen bond with CO group from S473. The hydrophobic tail of SHetA2 is deeply buried inside the substrate 
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binding cavity with strong hydrophobic interactions with F472 and T449. B) View from the other side of the substrate 
binding pocket of Mortalin. Additional hydrophobic interactions can be found between SHetA2 heteroatom ring with 
surrounding hydrophobic residues I447, I484, V482 and I518.  
 
 
Figure 39 The second configuration of SHetA2 binding to Mortalin with binding energy of -7.7 kcal/mol. The three 
hydrogen bonds between SHetA2 and Mortalin K576 and S470 stabilize the structure in this position. The hydrophobic 
heteroatom ring is shallowly buried inside the substrate biding cavity, in close proximity with residues V471 and S473. 
 
4.5 Improvements on small molecule structure to enhance binding 
Clinical studies showed that SHetA2 disrupts the interaction between Mortalin and p53, releasing 
p53 from the complex to translocate into the nucleus to regulate the apoptosis. We have proved 
SHetA2 can interact with Mortalin and this interaction could be the mechanism of how SHetA2 
competitively binds to the Mortalin substrate binding pocket, which most likely to be the p53 
interaction domain. However, multi-configurations of SHetA2 binding indicate this is not a stable 
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interaction. The fact that the chemical shift perturbation in the SHetA2 titration experiments 
didn’t not reach a saturation level even at 1: 8 molar ratio of protein: ligand further supports this 
conclusion. In order to investigate the binding preference of Mortalin to the small ligands, first, 
different SHetA2 analogs we have in hand were tested in the AutoDock to check their binding 
energy. A total of 31 different SHetA2 analogs were tested as listed in Table 5. 
Table 5 Binding Energy of SHetA2 analogs 





1) SHetA3-16  -8.54 
2) SHetA4-17  -8.46 
3) SHetC2  -8.31 
4) 4,4 - HPR  -8.43 
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5) SL-1-50  -7.98 
6) OHet72  -8.28 
7) All-trans-RA  -7.56 








10)   -8.27 
11)   -8.09 
12)   -7.53 
13)   -7.86 
14)   -8.65 
15)   -7.79 
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16)   -8.23 
17)   -7.81 
18)   -9.65 
19)   -9.15 
20)   -7.57 
21)   -8.05 
22)    -8.67 
125 
 
23)    -8.3 
24)   -8.5 
25)   -8.76 
26)   -9.58 
27)   -8.41 
28)   -8.44 
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29)   -8.63 
30)   -7.97 
31)  32)  -8.06 
 
Comparing the binding energies of difference analogs with different functioning groups, we find 
that the NO2 group on the aryl ring is more favorable comparing to the CO2 group, while COEt 
group would achieve the same binding energy level as the NO2 group. The Sulphur or Oxygen 
atom in the linker region does not make much difference to the binding energy considering they 
are chemically very similar. However, in the heteroatom ring, Sulphur and Oxygen substituted 
rings have very different biding energies, indicating Sulphur in the heteroatom ring instead of 
Oxygen is very important. While the heteroatom ring on one end, the other end has a better 
binding when it is a ring structure comparing to chain structure. When both ends of the molecule 
are hydrophobic heteroatom rings (No. 18), it yields the highest binding energy at -9.65 kcal/mol. 
In this molecule, one of the heteroatom ring was deeply buried inside the substrate biding pocket 
just like SHetA2, while the other end has close contact with Methionine (M584). The binding is 
different from SHetA2 where the Hydrogen bonding contributes more to the structure. We also 
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find that the molecules that are longer in structure bind better, which supports our findings in the 
NMR titration study. So if the molecule is long enough to occupy both configurations of SHetA2, 
it would have the highest biding affinity to Mortalin. 
It has been shown so far that SHetA2 could bind to Mortalin in the substrate binding pocket. 
However, there could potentially be multiple configurations according to the NMR titration data 
and AutoDock results. The fact that the chemical shift changes in the NMR titration experiments 
didn’t reach a plateau even at the 1:8, which is the highest concentration we can get for SHetA2, 
also indicates that there could be multiple configurations. Both the two lowest binding energy 
configuration of SHetA2 showed strong interactions with the sites that has significant chemical 
shift changes. However, configuration 1 was stabilized by the hydrogen bonds between the nitro 
groups on the SHetA2 and R513 on the protein. However, R513 was not significantly perturbed 
by the SHetA2 titration according to the NMR data. But the hydrophobic heteroatom ring of 
SHetA2 is deeply inside the substrate binding pocket of Mortalin, in close contact with I518 and 
V515, both of which show significant chemical shift changes on the perturbation experiments. In 
contrast, the configuration 2 was stabilized by the hydrogen bond between one of the nitro 
oxygen on SHetA2 and the side chain amide group of K576, which shows significant 
perturbation. However, the hydrophobic heteroatom ring is barely inside the cavity, resulting an 
unfavorable binding state (binding energy is higher comparing to configuration 1). All these 
evidences indicate that the binding of SHetA2 to Mortalin is a dynamic process. According to 
both the titration data and the small analogs we have been analyzed by AutoDock, we predict that 
if the linker region can be longer, and the molecule could reach to the K576 as well as keep the 
hydrophobic heteroatom ring inside the hydrophobic substrate binding pocket of Mortalin, it 
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should be the most favorable binding position. To test this idea, we designed several novel 
molecules to be tested on AutoDock as shown in Table 6. 
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First, we elongated the linker of SHetA2 from four bond thiourea chain to a six bond chain. In 
agreement with our previous predictions, the new structure analog 1 binds to Mortalin very well, 
and the binding energy is -9.56 kcal/mol. If we further elongate the linker to seven and eight 
bonds, the binding affinity further increases, with binding energy of -10.27 and -11.09 kcal/mol, 
respectively. Taking a look at their structures after docking in Figure 40A, all three hydrophobic 
heteroatom rings are almost at the same position inside the hydrophobic substrate binding pocket 
of Mortalin. The long arm is reaching out in contact with K576 on the helix of Mortalin. The 
longer linker between the two interacting region is more favorable so that the tension on the 
linker would be smaller, resulting a better binding affinity. The short arm has less freedom of 
rotation thus more rigid to constrain the structure. To further test our conclusion on the multi-
configurations of SHetA2, another set of small molecules (analog 4 to 7) was designed with the 
purpose to occupy all interaction sites from both configurations. All analogs 4 to 7 have two arms 
with different lengths. Analog 4 was designed with one arm the same as analog 1 and analog 6 
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was designed to with one arm the same as analog 3, analog 7 with an arm the same as analog 3, 
while analog 5 was designed to test the preference of double-double methyl group or single-
double methyl group on the heteroatom ring structure. According to the AutoDock results, with 
no surprise, analog 4 and 6 have significant lower binding energies to Mortalin comparing to the 
previous tested molecules. Checking the binding structure as shown in Figure 40B, both arms are 
occupying the positions exactly they are designed to bind. With the long arm reaching to the 
K576 forming hydrogen bonds, while the short arm forming hydrogen bonds with R513. And the 
longer arm analog 6 has an even lower binding energy comparing to the analog 4, in agreements 
with the differences between analog 3 and 1. Analog 5 shows a higher binding energy due to the 
double-double methyl group on the heteroatom ring that might affect the hydrophobic interactions 
inside the substrate biding pocket.  To test the effect of these methyl groups, analog 8 was 
designed with only single-double methyl groups comparing to analog 3, however, this does not 
increase its binding ability, potentially because in the single arm structure, the heteroatom ring 
has more space to move around inside the pocket to find a better binding sites, while in the 





Figure 40 Docking of Analog 3 and 6 into Mortalin. A) Analog 3, which possess a longer linker (8 bonds) comparing to 
SHetA2, is docked into the hydrophobic substrate binding pocket of Mortalin on the heteroatom ring end while the 
nitro group on the other end can reach to K576, forming a hydrogen bond. These are the strongest interactions shown 
in the NMR titration experiments. B) Analog 6, which were designed with two one extra arm can occupy both 
configurations of SHetA2, with hydrophobic interactions stabilizing the heteroatom ring in the substrate binding 
pocket, while the other two arms form hydrogen bonds with K576 and R513, respectively. 
 
Section 4 Conclusion 
SHeta2 has been clinically shown anti-apoptosis activity in cancer cells through disruption of 
Mortalin and p53 complex, releasing p53 to translocate into the nucleus to function as an 
apoptosis regulator. In this study, we investigate the structure of Mortalin using solution NMR, 
which indicates it has a high similarity to the crystal structure expect the more flexible 
unstructured C-terminus. We also demonstrate that SHetA2 interacts with Mortalin through 
binding to its substrate binding pocket with multiple configurations. Through this competitive 
binding, it disrupts the interactions between p53 and Mortalin. This mechanism can be further 
enhanced by designing new small molecule that occupy the interaction sites for both 
configurations of SHetA2. Our findings will definitely guide the chemical design of Flex-Hex 
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Section 1: The SNARE complex 
The SNARE complex is system that mediates the fusion of vesicles inside the neuron cell with 
the cell membrane, releasing the neurotransmitter inside of the vesicle to activate sub-stream 
receptors. The name of SNARE originated from a protein called N-ethylmaleimide-Sensitive 
Factor (NSF), which is sensitive to the small molecule N-ethylmaleimide. The NSF can bind to a 
protein called Soluble NSF Attachment Protein (SNAP). And its receptor is named SNAP 
REceptor (SNARE). The SNAP 25 comes from SyNaptosome Associated Protein of 25 kD. In 
mouse, the SNARE complex consist of three proteins, Syntaxin 1A, SNAP 25 and Synaptobrevin, 
all of which contain the SNARE motif. These motifs together form the four helix bundle which 
pulls close of the vesicle and cell membrane to mediate membrane fusion. This complex is 
resistant to SDS but can be disassociated by heat (over 95 °C). 
All four SNARE motifs (Syntaxin 1A, both motifs of SNAP25, Synaptobrevin 2) from rat were 
cloned, expressed and purified, respectively. The complex were formed by incubating all purified 
components at a 1:1:1:1 ratio at 4 °C for 24 hours. We found that the SNARE complex can be 
formed after the incubation, however, not only the 1st order complex (which consists one 
component each), the higher order complex (oligomers of the complex) can also be found as 
indicated in the SDS-PAGE gel. The SNARE complex formation also showed a dynamic balance 
between the complex and the components. The higher concentration of the components, the more 
complex formed. However, there were always components left in the sample, no matter 
reconstitute first or forming complex first, making it hard to get a pure sample of the SNARE 
148 
 
complex to study its structure.  
 
 
Figure 41 Purification of all four SNARE motifs and the dynamic formation of SNARE complex. On the left, all four 
SNARE motifs are purified and checked by the SDS-PAGE. On the right, we show that the SNARE complex is in a 
dynamic balance between the complex and components. With decreasing concentration from left to right, more high-
order complex were disassociated. The first order complex remains almost the same concentration (the band in the 
middle). 
 
Section 2: The aligned NMR 
Application of NMR on the solid sample results broad spectra due to the chemical shift 
anisotropy, which is averaged out by Brownian motion in the liquid. However, in solid, chemical 
shift anisotropy is dominant. One way to overcome is the Magic Angle Spinning (MAS), in 
which the sample was placed 54.74 ° with respect to the external magnetic field. So the 
anisotropy term was effectively eliminated due to the (3cos2θ-1) will become 0 for the anisotropy.  
Another way to go around is to align the samples in a certain direction so that the chemical shift 
anisotropy aligned into one direction and the orientation of the membrane protein can be accessed 
by a specifically designed pulse sequence. The lipids can aligned automatically under eternal 
149 
 
magnetic field, which makes a perfect system to study membrane proteins. Here, we tried to align 
the DMPC/DHPC bicelle (at a ratio of q = DMPC: DHPC = 3.5: 1) and the sample aligned very 
well in the magnet after 2.5 hours equilibration. The alignments can be probed by the 31P NMR. 
The two distinct peaks are coming from the phosphorus belonging to the head group of each lipid 
molecule, respectively, with about 8 ppm separation (Figure 42). The small peptide Fowlicildin 
was mixed with the aligned bicelle sample and the same alignments of lipids can be achieved 
telling by 31P spectrum. However, the 13C signals were relatively low and 15N cannot be found. 
With either 2 ms or 0.5 ms contact time with 1 k scans.  It was reported longer contact time 
results more signals from mobile region of the peptide and shorter contact time results more 
signals from rigid regions. However, we haven’t been successful on acquiring the lower sensitive 





Figure 42 31P 1D spectrum of aligned DMPC/DHPC bicelle sample. The DMPC/DHPC lipids are mixed with q=3.5 and 
aligned under a 400 MHz magnet for 2.5 hours. The distinct two peaks shown in the 31P spectrum are coming from 
the head group phosphorus from the head group of each lipid, respectively. The 6 ppm peak is from DHPC, which is 
parallel to the external magnetic field after alignments and 14 ppm peak is from DMPC which is perpendicular to the 
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